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ABSTRACT
Hypertension affects 50 million Americans and remains the second leading cause of renal
failure in the United States. Current pharmacological and non-pharmacological approaches to
treat hypertension have proven effective, but the complexities of the disease and its renal effects
warrant the need for new treatments. The hypothesis of this dissertation was that
pharmacological or non-pharmacological approaches to reducing inflammation and oxidative
stress would prevent hypertension-induced renal injury in the spontaneously hypertensive rat
(SHR).
In the first study, we blocked the inflammatory transcription factor, nuclear factor-kappa
B (NF-ĸB), with pyrrolidine dithiocarbamate in the SHR kidney. In treated SHR, blood pressure
decreased, renal hemodynamics were preserved, and oxidative stress and inflammation were
attenuated at both the cytosolic and mitochondrial levels; suggesting a role for NF-ĸB in
potentiating hypertension-induced renal injury.
In the second study, we examined the effects of aerobic exercise training on renal
oxidative stress and inflammation. Exercised SHR exhibited normalized blood pressure and renal
hemodynamics. These effects were attributed to lower NF-ĸB activity and decreased oxidative
stress in the SHR kidney. In the third and fourth studies, we examined the effects of diet
modification by use of blueberry-enriched diets, since blueberries have one of the highest
antioxidant capacities of any fruit or vegetable tested to date.
In the third study, we fed stroke-prone SHR high salt and a blueberry-enriched diet for 2
days, 6 weeks, or 12 weeks, and examined renal parameters. The SHR fed the blueberry diet for
the 6- or 12-week periods demonstrated lower oxidative stress, lower blood pressure, and
preservation of renal hemodynamics. These effects were likely due to a hormetic effect of the
xi

blueberries themselves, since rats fed blueberries for 2 days demonstrated higher oxidative stress.
In the final study, we added blueberries to a stroke-permissive diet, which accelerates renal
damage in SHR. Rats were fed diets for 10 weeks. Rats fed the control diet had severe
hypertension, severe oxidative stress, and severe inflammation as evidenced by NF-ĸB
activation, and exhibited signs of renal failure. Rats fed the blueberry supplemented diet
exhibited decreases in blood pressure, oxidative stress, and inflammation, and also had preserved
renal structure and function.

xii

CHAPTER 1
REVIEW OF LITERATURE
Arterial Pressure
Blood pressure is the force exerted by circulating blood on the walls of the arteries and
veins. Venous pressure is commonly very low and does not significantly factor into the
determination of blood pressure; therefore, the term ‘arterial pressure (AP)’ is often used. With
each heartbeat, the AP varies between systolic and diastolic pressures. Systolic pressure is the
peak pressure in the arteries, which occurs near the end of the cardiac cycle when the ventricles
are contracting to eject blood. Diastolic pressure is the minimum pressure in the arteries, which
occurs near the beginning of the cardiac cycle when the ventricles are filled with blood.
Maintenance of AP at a homeostatic level - one that allows for adequate blood supply to
the body tissues - is critical to the survival of mammals. Several mechanisms exist that maintain
homeostatic AP, even in situations that are stressful to the body, including: alterations in salt and
water intake, and hemorrhage [1]. Some mechanisms function rapidly and are responsible for
minute-to-minute regulation of AP, while others are responsible for regulating AP over longer
time periods. Other mechanisms are involved in both short- and long-term regulation of AP.
The involvement of hormonal and neural factors in determining and maintaining AP is wellestablished; however, the kidney’s dominance of the long-term regulation of AP is clear. Guyton
and colleagues first proposed the theory that AP is sustained at a ‘set-point’ required by the
kidneys to maintain a balance between intake and excretion of sodium and water [1].
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Hypertension
Overview and Prevalence
Hypertension (HTN), or persistently high AP, is the most common primary diagnosis in the
United States [2]. Current estimates indicate that approximately 73.6 million (one in three)
Americans presently suffer from HTN, and that 22% of these individuals are undiagnosed [2].
Hypertension is often called the “silent killer”, due to the considerable damage it inflicts while
the patient remains asymptomatic. The devastating effects of HTN are not limited to a single
tissue; rather, they adversely affect most organs and organ systems [2]. Hypertension is a major
contributing factor to atherosclerosis, which causes an increase in the relative workload for the
heart, which must pump blood under greater peripheral resistance. Over time, the greater
workload may result in myocardial infarction and/or heart failure. The brain and its delicate
arteries can also be affected by HTN. Over time, these vessels may rupture, resulting in brain
hemorrhage or cerebrovascular accident (stroke). Finally, and arguably most importantly, HTN
can result in thickening or disease of the arteries and arterioles of the kidneys, thereby decreasing
glomerular filtration rate and renal blood flow. In response to these alterations, the kidneys may
secrete renin, which elevates AP further and perpetuates this positive feedback cycle.
Risk Factors for Hypertension
The risk factors for HTN can be classified into two categories: non-controllable and
controllable. Non-controllable risk factors for HTN include age, gender, genetic predisposition,
and ethnicity. Controllable risk factors are those that can be altered, such as high salt or high fat
diet, excess body weight, smoking, and lack of exercise.

In the United States, African-

Americans have a higher prevalence of HTN than do non-Hispanic whites [3, 4]. The morbidity
associated with HTN is also more severe among African-Americans and is thought to develop
2

earlier in life [5]. Age is another important factor in the development of HTN. Longitudinal
research studies have found increases in AP with age, with diastolic pressure peaking around age
50 and systolic pressure rising throughout life [6-8]. Recently, an increased prevalence of HTN
has been noted among adolescents as a result of obesity, diet, and a sedentary lifestyle [9]. If
these cases remain uncontrolled, morbidity and mortality may result for these individuals at
significantly earlier ages. Gender also influences the onset of hypertension [9]. Hypertension is
less prevalent in women in early adulthood; however, the incidence of HTN increases rapidly in
women above the age of 40. The prevalence of hypertension in females equals or possibly
exceeds that in men by age 50 [9].
Classification
Hypertension can be classified as primary (essential) or secondary [4]. The term essential
hypertension encompasses about 90-95% of all diagnosed cases, and is clinically defined as an
elevation in AP of unknown etiology [4]. Secondary hypertension represents about 5-10 % of
al1 diagnosed cases and can generally be reversed with correction of the underlying cause [10].
Despite the extensive research efforts of recent years and the current knowledge of the
physiology of AP regulation, the basis of essential HTN in most patients remains elusive.
Patients are categorized, based on systolic and diastolic AP readings, as either normotensive,
prehypertensive, or hypertensive [4, 9]. The National Heart, Lung and Blood Institute further
divides the hypertension classification into two stages (Table 1.1), with stage two being the more
severe stage.
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Table 1.1 Classification of hypertension, based on the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [2].
Category
Normal
Prehypertensive
Hypertension (Stage 1)
Hypertension (Stage 2)

Systolic Blood
(mmHg)
<120
120-139
140-159
≥160

Pressure
and
or
or
or

Diastolic Blood Pressure
(mmHg)
<80
80-89
90-99
≥100

Kidney Redox Mechanisms in Hypertension
Hypertension-induced kidney disease is a significant cause of morbidity and mortality in
hypertensive patients [11]. Current anti-hypertensive treatments are mostly effective in reducing
the severity of hypertensive renal disease; however, the progressive clinical course of the disease
underscores the need for additional novel therapies. The progression of hypertensive kidney
involves increased pro-inflammatory cytokine (PIC) and reactive oxygen species (ROS)
production, and on nuclear factor-kappa B (NF-κB) activation [12, 13].
Renal Inflammation and Hypertension
Increasing evidence supports a role for inflammatory molecules in the pathogenesis of
hypertension [14]. In the kidney, tubulointerstitial inflammation is accompanied by activation of
NF-κB [15, 16] which is the general transcriptional factor for many proinflammatory cytokines,
chemokines, and adhesion molecules. A role for renal inflammation in the pathogenesis of
hypertension is demonstrated by a number of animal studies that have shown attenuation of
hypertension with anti-inflammatory compounds, including mycophenolate mofetil and NFkappa B inhibitors [17-20]. We recently reported decreased plasma concentrations and renal
gene and protein expression of the proinflammatory cytokines tumor necrosis factor-alpha (TNFα), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) in spontaneously hypertensive rats (SHR)
treated with pyrrolidine dithiocarbamate (PDTC) [21].
4

Those animals also had decreased

glomerular desmin expression when compared to untreated SHR, which is indicative of less
glomerular damage in these animals, presumably due to a decrease in the inflammatory
condition.
Vascular inflammation also affects the kidney during hypertension. A major factor
underlying this type of inflammation is modulation of proinflammatory gene expression via
redox-sensitive transcription factors [20, 22]. Angiotensin II (AngII) has an important role in
modulating expression of pro-inflammatory molecules in the vasculature [14]. AngII induced the
release of IL-6, which caused the recruitment of inflammatory cells from human vascular smooth
muscle cells into the vessel media; this release required the production of ROS and activation of
NF-κB [23]. Also involved in pro-inflammatory gene transcription are the Janus kinase/signal
transducers and activators of transcription factors (JAK/STAT) pathways. These pathways can
be activated by exogenous hydrogen peroxide, other ROS, and AngII [24, 25].
A number of the pathways responsible for adhesion molecule expression in the kidney
are also redox-sensitive [26]. In the double transgenic rat, a model of overactive reninangiotensin system (RAS) and oxidative stress, vascular cell adhesion molecule-1 (VCAM-1)
and intracellular adhesion molecule-1 (ICAM-1) expression are elevated in the small renal
vessels [27]. Further, ICAM-1, VCAM-1, and monocyte chemoattractant protein-1 expression
levels were all reduced in a salt-sensitive hypertension rat model after blockade of TNF-α [28].
AngII-infused hypertensive rats also demonstrate increased VCAM-1 expression due to NF-κBmediated transcriptional events [29].
Renal Oxidative Stress and Hypertension
In normal conditions, mammalian cells reduce molecular oxygen to water during aerobic
respiration. During this process, ROS are generated that include superoxide, hydroxyl radicals,
5

and hydrogen peroxide; these highly reactive species may interact with proteins, lipids, and
deoxyribonucleic acids (DNA) [30, 31]. Normally, the in vivo antioxidant defense is sufficient
to metabolize these ROS; however, in conditions of persistent oxidative stress, antioxidant
molecules and enzymes can be depleted and inactivated, thereby impairing the overall
antioxidant defense system [31]. Excessive ROS production causes oxidative damage and is
associated with hypertension [32, 33] and other diseases. The major producers of these ROS
include plasma membrane-bound nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases and mitochondria [21].
ROS also have an important role in the inactivation of nitric oxide (NO) [34, 35]. When
oxidative stress occurs, endothelial dysfunction and reduced NO bioavailability will result,
usually from superoxide binding to NO to form peroxynitrite [34, 36]. This reduced NO
bioavailability leads to several processes that contribute to hypertension: inflammation with
increased proinflammatory cytokine production, lipid peroxidation, and increased vascular
contractility [37]. We have demonstrated increases in production rates of superoxide, total ROS,
and peroxynitrite in the kidneys of spontaneously hypertensive rats; these increases were
attenuated with the administration of the antioxidant and NF-κB inhibitor, PDTC [21].
Oxidative stress contributes to hypertension, endothelial/vascular dysfunction, and brain
disorders in animals with chronic kidney diseases. This is partly due to the up regulation of
NADPH oxidase and the down-regulation of superoxide dismutase (SOD) [15, 22, 30]. Several
studies, including one from our lab, support the hypothesis that uremia in renal disease is
associated strongly with oxidative stress. We demonstrated increased plasma creatinine (Cr) and
blood urea nitrogen (BUN) levels, along with decreases in glomerular filtration rate (GFR) and
renal blood flow (RBF), in SHR (a model of increased oxidative stress) [21]. Oxidative stress is
6

also known to exacerbate renal injury. In patients with end stage renal disease, hemodialysis or
peritoneal dialysis treatment for longer than two years can lead to further reduction of
antioxidant levels and increased oxidant levels, thereby perpetuating the oxidative stress seen in
these patients. Further, there is a greatly decreased potential for scavenging of oxygen radicals
after about seven years of hemodialysis in patients [38]. Therefore, the treatments for renal
failure can also aggravate the oxidative stress that initially contributed to the disorder.
The Relationship Between Oxidative Stress and Inflammation in the Kidney
The relationship between inflammation and oxidative stress is notable. Oxidative stress
can activate NF-κB [31, 39] and activator protein-1 [31], stimulating production of chemokines,
cytokines, and adhesion molecules, as well as activation and proliferation of lymphocytes.
Immune cell activation, adhesion, and infiltration result from these events. Conversely,
inflammation can result in oxidative stress, since ROS production is an inherent property of
activated immune cells. Renal inflammation is thought to be a key mediator in the development
and progression of hypertension, and compelling evidence suggests that ROS overproduction and
NF-κB activation promote glomerular and tubulointerstitial inflammation in rat models of
hypertension [40, 41]. Blockade of NF-κB or of ROS has demonstrated both anti-hypertensive
and anti-inflammatory effects in rats [17, 42, 43]. Further, immune cells infiltrating the kidney
have been shown to produce ROS in hypertensive animals and humans [30]. Thus, oxidative
stress and inflammation seem to be involved in a vicious, self-perpetuating positive feedback
cycle.
Role of Kidney RAS in Inflammation and Oxidative Stress
Angiotensin II stimulates salt retention directly in the proximal tubule and indirectly via
aldosterone in the distal tubule, and also causes vasoconstriction [44]. In addition to these
7

common physiological effects, AngII also activates the angiotensin II type 1 (AT-1) receptor,
resulting in renal ROS generation via the up regulation of NADPH oxidases [44-46]. The ROS
produced by increased NADPH oxidase expression and activity can activate NF-κB [45].
Angiotensin II can also directly activate NF-κB in various renal cells, including mesangial and
endothelial cells, which leads to inflammation in these tissues [47, 48]. Inflammation can also
increase the expression of several components of renal RAS, including AngII, renin, and AT-1
receptor [49, 50].

A variety of animal studies have shown marked up regulations of RAS

components in the kidneys of hypertensive animals [49, 51-53]. In renal damage associated with
activated RAS, increased renal NF-κB activity was diminished by angiotensin converting
enzyme (ACE) inhibition [54-56]. We and others have demonstrated that the blockade of NF-κB
can improve renal tissue damage and renal hemodynamics [21, 57]. In vivo, systemic infusion
of AngII into normal rats increases NF-κB activity in the vasculature and the kidney [58].
Therefore, the RAS and NF-κB appear to be involved in another vicious cycle that contributes to
hypertension, inflammation, and renal damage.
Pharmacological Treatment of Hypertension
Substantial clinical trial outcome data exist to support the use of several classes of
pharmaceuticals to reduce hypertension and its associated complications [59-63]. Commonly
used classes of drugs include: thiazide-type diuretics, ACE inhibitors, angiotensin receptor
blockers (ARBs), calcium channel blockers (CCBs), and beta blockers [9].

Thiazide-type

diuretics have long been the basis of antihypertensive therapy. In most clinical trials, including
the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
[64], diuretics have gone unsurpassed in preventing the cardiovascular complications of
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hypertension, and can also enhance the antihypertensive efficacy of combination drug regimens,
and are more affordable than other antihypertensive agents [64].
In the last decade, several large trials comparing the newer antihypertensive agents,
including CCBs, ACE inhibitors, and an ARB, with commonly prescribed diuretics and/or beta
blockers have been completed [60, 61, 63, 64]. Most of these studies demonstrated that these
newer antihypertensives were neither superior nor inferior to the older drugs in terms of efficacy.
However, more than two-thirds of hypertensive individuals will require two or more
antihypertensive agents selected from different drug classes for adequate treatment of
hypertension [60, 61, 65].
Non-Pharmacological Treatment of Hypertension
Extensive published evidence supports the concept that non-pharmacological
interventions (also referred to as lifestyle modifications), can substantially reduce blood pressure
(BP) in individuals with established hypertension or with prehypertension. Epidemiological data
has implicated several dietary and other lifestyle-related factors in contributing to the
development of hypertension. These factors include: habitual high sodium intake, low potassium
intake, decreased physical activity, high body mass index, and excess alcohol intake [66, 67].
Aerobic Exercise Training
A sedentary lifestyle is a well-established independent risk factor for cardiovascular
diseases. Epidemiological evidence suggests that a greater level of physical fitness is associated
with lower BP and a reduction in morbidity and mortality from cardiovascular events [68].
Regular physical activity can reduce the risk of developing hypertension by 30-50 % [68].
Further, regular moderate physical activity has been shown to decrease systolic BP by 6-10
millimeters of mercury (mmHg) and diastolic BP by 4-8 mmHg in patients with essential
9

hypertension [69]. In a meta-analysis of 54 randomized controlled trials with a sample size of
approximately 2400, aerobic exercise training (ExT) was associated with a statistically
significant reduction in BP [70]. This BP reduction was similar in normotensive and
hypertensive participants. Perhaps most importantly, mean BP reduction was not associated with
changes in body weight, and BP was reduced significantly, even in participants that did not lose
weight.

The mechanisms surrounding BP reduction with aerobic exercise training remain

unclear; however, a reduction in vascular resistance is thought to be a major effect. Decreased
oxidative stress is also thought to play a role in BP reduction in response to ExT [69].
Six weeks of moderate intensity ExT was found to preserve renal function (as indicated
by increased natriuresis and decreased proteinuria) by decreasing oxidative stress and improving
antioxidant defense in the aged rat kidney [71]. A recent study in obese rats found that five
weeks of ExT prevented albuminuria and oxidative stress and decreased nuclear translocation of
NF-ĸB in the kidney [72]. Interestingly, ExT can also improve oxidative stress from renal injury
prior to the renal injury occurring. Normotensive rats were subjected to ExT for eight weeks and
then underwent 5/6 nephrectomy to induce chronic kidney disease.

When compared to

nephrectomized sedentary rats, the nephrectomized rats subjected to ExT had decreased
superoxide production and oxidative insult but no significant improvement in renal function [73].
Further, basal urinary nitrate/nitrite excretion increases with increasing levels of physical activity
and these levels are also significantly increased after ExT in patients with coronary artery disease
[74].
Diet Modification
In addition to weight loss and regular physical activity, reduction of sodium intake and
consumption of a diet rich in low fat dairy products, fruits, and vegetables (and therefore high in
10

vitamins, minerals, and antioxidants) have been shown to improve BP [75]. The most recent
guidelines set forth by the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure recommend the adoption of this type of diet [9, 75], which
was formulated for the Dietary Approaches to Stop Hypertension (DASH) study.
The DASH study tested the effects of an overall healthy diet on BP in participants with
prehypertension or stage I hypertension [67]. A total of 459 adults with BP <160/80–95 mmHg
were randomly assigned for 8 weeks to one of the following diet groups: 1) control diet = low in
fruits, vegetables, dairy products with a fat content typical of the average American diet, and
with potassium, magnesium, and calcium levels close to the 25th percentile of consumption; 2)
fruit and vegetable diet = potassium and magnesium at 75th percentile and high in fiber; or 3)
combination diet = rich in fruits, vegetables, and low-fat dairy, with reduced saturated fat, total
fat, and cholesterol, and potassium, magnesium, and calcium at the 75th percentile of
consumption [67, 75]. Study diets each had a sodium content of approximately 3 grams per day.
Interestingly, the combination diet group experienced the most significant decrease in BP; this
reduction began during the second week of the diet. Further, the combination diet was found to
be as effective in reducing BP as some drug monotherapies. It was therefore concluded that the
DASH combination diet might be an effective alternative to pharmacotherapy in patients with
stage I hypertension and may provide an opportunity to those patients to delay the start of an
antihypertensive drug regimen [67, 75].
The Spontaneously Hypertensive Rat
The spontaneously hypertensive rat (SHR) is a rat strain developed by Okamoto and Aoki
in the 1960s by selectively breeding male rats from the Wistar-Kyoto (WKY) strain with BP
persistently in the range of 150 – 175 mmHg with WKY females with BP of 130-140 mmHg
11

[76]. Selective breeding continued until a strain was developed where males develop chronic
essential hypertension beginning at approximately 8 weeks of age, with systolic BP often
exceeding 200 mmHg [76].

This genetically hypertensive strain is also known to exhibit

increased sympathetic nervous system activity, increased RAS activity, and increased oxidative
stress [77]. The SHR is a widely used model of human hypertension because it develops many
features of hypertensive end-organ damage, including cardiac hypertrophy, cardiac failure, and
renal dysfunction [77]. Because the SHR was developed from the WKY rat, the WKY is often
used as the normotensive control for this strain.
Blueberries (Vaccinium Species)
Constituents and Bioactive Components
North American blueberry (BB) species include highbush blueberry (V. corymbosum)
and lowbush blueberry (V. angustifolium). Highbush BB are cultivated as unique varieties, while
lowbush BB grow in the wild. The antioxidant capacity of BB is among the highest of fruits and
vegetables [78, 79]. Although BB are rich in vitamins and minerals [80], the contribution of
these micronutrients to the antioxidant capacity of BB is minimal [81]. Blueberries contain high
levels of flavonoids and polyphenols [81], and are especially high in anthocyanidins.
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anthocyanidins are commonly found in nature, and BB contain five of these anthocyanidins [82].
Malvidin, delphinidin, cyanidin, petunidin, and peonidin are found in all Vaccinium species, and
are usually found in the form of anthocyanidin glycosides, which are referred to as anthocyanins
(from the Greek words “anthos” = flower and “kyanos” = blue) and are responsible for giving
BB their unique coloring [82]. Anthocyanins play a vital role in the skin of the blueberry by
protecting the fruit’s flesh from overexposure to ultraviolet light.
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Significant differences exist in both the types of anthocyanins and total anthocyanin
content among Vaccinium subspecies [83]. North American wild lowbush BB have higher total
anthocyanin levels per 100g of fresh weight than do highbush BB; this is because the majority of
anthocyanins are present in the skin of the berry and lowbush BB have a greater amount of
surface area per volume of fruit [83]. However, highbush BB are generally the only variety of
blueberry available as a whole, relatively unprocessed fruit (either fresh or frozen) in grocery
stores. Lowbush BB are used predominantly in processed foods and in flavored yogurt [84, 85].
Processing significantly affects the antioxidant capacity of BB and blueberry products [84, 85].
Although freezing is a form of processing and does result in loss of antioxidant capacity, frozen
BB and fresh BB purees retained higher levels of unoxidized anthocyanins than all other forms
of processed BB and BB products measured in a study by Kalt and colleagues [85].
Blueberries and Chronic Disease
Many studies have demonstrated the anti-hypertensive benefits associated with
consuming diets high in fruits and vegetables; yet there have been very few studies examining
the relationship between BB consumption and hypertension, and no studies examining the effects
of BB on renal function. However, many recent studies have demonstrated the benefits of BB
consumption on brain function [86-90]. A study by Joseph and colleagues examined whether
foods with high antioxidant activity, including BB, could reverse age-related declines in neural
and behavioral functions. Forty 19-month old male rats were assigned to one of four treatment
groups: control, 1.48% strawberry, 0.91% spinach, or 1.86% BB [89]. The percentages of each
of these foods in the diets were based on oxygen radical absorbance capacity (ORAC), to ensure
that each diet provided an equivalent amount of antioxidants. Diets were fed to rats for eight
weeks before neural and psychomotor behavior testing. All foods tested prevented age-related
13

neuronal and behavioral dysfunction, with BB supplementation showing the greatest effect on
reversing the deleterious effects of aging on calcium homeostasis. Further, the BB-fed rats were
the only animals that exhibited reversals in motor behavioral deficits [89]. The feeding of a
14.3% BB diet to male Long-Evans rats for six weeks before carotid artery ligation (to induce
stroke) was found to be protective against ischemia-induced hippocampal injury [90]. One week
after carotid ligation, rats on the BB diet had only a 17% loss of neurons to the ischemic
hippocampus compared to a 40% loss in the control group, suggesting that blueberries can
protect against ischemic brain injury [90].
One recent study by Ahmet and colleagues examined the effects of BB consumption on
ischemic injury in the heart [91]. Fischer rats were fed a control diet or a BB-enriched diet for 3
months. Mitochondrial permeability transition of cardiomyocytes was assessed in seven rats
from each group after the 3-month feeding period, and those animals fed a BB-enriched diet
demonstrated a 24% increase in mitochondrial permeability transition threshold, indicating an
improvement in mitochondrial integrity with BB feeding. Animals from each group were also
subjected to myocardial ischemia by coronary artery ligation, and resulting infarct size was 22%
less in rats fed the BB-enriched diet, suggesting an overall cardioprotective effect of blueberries
[91].
The only study to examine the effects of blueberry consumption on blood pressure was
conducted by Shaughnessy and colleagues in the stroke-prone spontaneously hypertensive rat
[92]. Stroke-prone SHR and normotensive control rats were fed a control diet or a 3% BB diet
for 8 weeks. Systolic blood pressure was 19% lower after 4 weeks in SHR fed the BB diet, and
was 30% lower after 8 weeks. Proteinuria and kidney nitrites were also lower in these animals,
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suggesting that BB may prevent oxidative damage in the kidney [92]. However, no detailed
measurements of renal structure or function were performed in that study.
Statement of the Problem and Specific Aims
Increased oxidative stress and inflammation perpetuate a vicious positive feedback cycle
that can exacerbate the hypertensive condition and, if left unchecked, can lead to damage of
organs such as the kidney. The redox-responsive transcription factor, NF-ĸB has been shown to
contribute to the deleterious effects of reactive species and inflammatory molecules on kidney
structure and function. Although obvious putative roles exist for oxidative stress and NF-ĸB in
the development and progression of hypertension-induced renal disease, the exact signaling
mechanisms that perpetuate their effects on the hypertensive kidney remain unclear. The overall
hypothesis of this dissertation was that pharmacological or non-pharmacological approaches to
reducing both inflammation and oxidative stress would prevent or delay hypertension-induced
renal injury in the spontaneously hypertensive rat (SHR), a model for human essential
hypertension. We performed a series of in vivo experiments, integrated with various
physiological and molecular techniques, to fulfill the following aims:
Aim 1: Determine the benefits of pharmacological NF-ĸB blockade on hypertensioninduced renal injury in SHR.
Aim 2: Determine the benefits of exercise training as a non-pharmacological modality
for prevention or treatment of hypertension-induced renal injury in SHR.
Aim 3: Examine the short-term and long-term effects of a blueberry-enriched diet on
hypertension induced renal injury in stroke-prone SHR.
Aim 4:

Examine the effects of a blueberry-enriched stroke-permissive diet on

hypertension and hypertension-induced renal injury in salt-loaded stroke-prone SHR.
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CHAPTER 2
CHRONIC NF-κB BLOCKADE REDUCES CYTOSOLIC AND MITOCHONDRIAL
OXIDATIVE STRESS AND ATTENUATES RENAL INJURY AND HYPERTENSION
IN SHR*
Introduction
Hypertension-induced kidney disease is a significant cause of morbidity and mortality in
hypertensive patients [93]. Current anti-hypertensive treatments are mostly effective in reducing
the severity of hypertensive renal disease; however, the progressive clinical course of the disease
underscores the need for additional novel therapies. The progression of hypertensive kidney
disease depends not only on neurohormones, such as norepinephrine and aldosterone, but also on
increased proinflammatory cytokine (PIC) and reactive oxygen species (ROS) production, and
on nuclear factor-kappa B (NF-κB) activation [94, 95]. Increased production of ROS, which
include superoxide and hydrogen peroxide, is a particularly detrimental aspect of renal disease
progression [95].

The major producers of these ROS include plasma membrane-bound

NAD(P)H oxidases and mitochondria.
Mitochondria are critical modulators of ATP generation and redox-dependent
intracellular signaling. The mitochondrial respiratory chain continuously releases ROS during
oxidative phosphorylation. Approximately 90% of the cellular oxidative burden is attributed to
mitochondrial ROS, thus signifying the role of mitochondria in cellular ROS production [96]. In
normal physiological conditions, small amounts of ROS are needed for critical cellular
processes; however, excessive ROS production causes oxidative damage and is associated with
hypertension [97, 98] and other diseases.

The contributions of ROS to the regulation of

*
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intracellular signaling pathways, including NF-κB activation, are already known. Excess ROS
activate the redox-sensitive transcription factor NF-κB, causing increases in its activity and
expression [99, 100]. Increased activity and expression of NF-κB induces gene transcription for
PIC, such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6, to
increase their production [99, 101]. Increased levels of PIC, along with adhesion molecules, lead
to macrophage infiltration of the tubulointerstitium and inflammation of renal tissue [102, 103].
However, the roles of NF-κB and of ROS in modulating renal function and tissue injury in
hypertensive renal damage have not yet been examined.
Evidence from our laboratory indicates that peripheral TNF-α administration increases
ROS production in rat myocardial tissue and mitochondria [104]. Findings from other labs also
indicate that TNF-α augments ROS production in liver mitochondria and endothelial cells [105,
106]. IL-6-dependent ROS production has been noted in fibroblasts and in endothelial cells [107,
108]; and fibroblasts have previously been shown to release ROS in response to IL-1β and TNFα [109]. Taken together, these data support a role for NF-ĸB-regulated PIC in cytosolic and
mitochondrial ROS production in a variety of tissues. Therefore, it is plausible to suggest that
NF-κB blockade (and, therefore, blockade of PIC gene transcription) may improve the redox
status of hypertensive renal cortical tissue and mitochondria.
Renal inflammation is thought to be a key mediator in the development and progression
of hypertension, and compelling evidence suggests that ROS overproduction and NF-κB
activation promote glomerular and tubulointerstitial inflammation in rat models of hypertension
[110, 111]. Further, blockade of NF-κB or of ROS has demonstrated both anti-hypertensive and
anti-inflammatory effects in rats [112-114].

However, the effects of NF-κB blockade on

mitochondrial ROS and the roles of these ROS in modulating renal function and tissue injury in
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hypertension are unknown. The aim of this study was to examine the effects of long-term NF-κB
blockade on cortical cytosolic and mitochondrial ROS production and on renal function during
hypertension, and to investigate the contributions of these ROS to hypertensive renal injury. We
hypothesized that long-term NF-κB blockade with pyrrolidine dithiocarbamate (PDTC) would
decrease both cytosolic and mitochondrial ROS production in the kidney cortex, thereby
protecting the kidneys from damage, and resulting in improved renal function parameters in
spontaneously hypertensive rats (SHR).
Materials and Methods
All experimental procedures with animals were approved by the Louisiana State
University Institutional Animal Care and Use Committee, and were performed in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Chemicals and Drugs
Inulin (polyfructosan-S; Inutest) was obtained from Fresenius-Kabi (Graz, Austria) and
para-aminohippurate (PAH) was obtained from Merck, Sharp & Dohme (West Point, PA). The
spin probes 1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine (CMH), 1-hydroxy3-carboxypyrrolidine (CPH), and 1-hydroxy-4-phosphono-oxy-2, 2, 6, 6-tetramethylpiperidine
(PPH); the metal chelators defferoxamine (DF) and diethyldithiocarbamate (DETC); and KrebsHEPES buffer (KHB) were obtained from Noxygen Science Transfer and Diagnostics (Elzach,
Germany). Polyethylene glycol-conjugated superoxide dismutase (PEG-SOD), thiobutabarbital
(Inactin), and pyrrolidine dithiocarbamate (PDTC) were obtained from Sigma-Aldrich (St. Louis,
MO). All other chemicals and reagents used were of analytical grade and were purchased from
Sigma-Aldrich unless otherwise specified.
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Experimental Protocol
Eight-week old male Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats
(SHR), obtained from Harlan (Indianapolis, IN), with initial body weights between 200-250
grams, were used in this study. Animals were housed in temperature- (23 ± 2°C) and lightcontrolled (12-hour light/dark cycle) animal quarters. Four groups of 6 rats each were used:
WKY, WKY+PDTC, SHR, and SHR+PDTC. All animals were allowed ad libitum access to
standard rodent chow (LabDiet; Purina Mills Inc., St. Louis, MO). Control animals were given
access to tap water ad libitum; PDTC-treated rats were allowed ad libitum access to tap water
with PDTC added. Beginning at 8 weeks of age, the appropriate groups of rats were treated with
PDTC dissolved daily in drinking water for 15 weeks. At 8 weeks of age, SHR are still
normotensive [115], therefore, we initiated treatment for all animals at this age. For the first
week of the study, PDTC was added to drinking water at an initial concentration of 50 mg/kg;
the concentration was increased by 25 mg/kg daily until the final concentration of 150 mg/kg
was attained; this was done to allow for adaptation to changes in taste. At the end of week 13,
rats were placed into metabolic cages for a one-week acclimatization period. Immediately
following acclimatization, daily urine output was measured for one week.

Animals were

sacrificed at the end of week 15, after completion of renal clearance experiments. Plasma and
kidney tissues were collected for later analyses.
Blood Pressure Measurement
Blood pressures for all animals were measured by the tail-cuff method at baseline and
every third week using a Coda 6 Blood Pressure System (Kent Scientific, Torrington, CT) for the
duration of the study as previously described [116]. Animals were habituated to the blood
pressure system for 3 days prior to starting the experiment. Rats underwent two daily cycles of
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20 measurements each for a minimum of 3 days per week. Body temperatures were monitored
for the duration of each blood pressure measurement.
Renal Clearance Experiments
At the end of 15 weeks’ treatment, acute clearance experiments were performed to
determine renal function in anesthetized (thiobutabarbital, 100 mg/kg; intraperitoneally) rats, as
described previously [117]. In brief, the right inguinal area was shaved, a small (< 2 cm)
incision made, and femoral vessels isolated. The right femoral artery was cannulated with
heparin-primed (100 U/ml) polyethylene tubing (PE-50) and then connected to a pressure
transducer (PowerLab data acquisition system; ADInstruments, Colorado Springs, CO) for
continuous measurement of arterial pressure. The right femoral vein was catheterized with
heparin-primed PE-50 tubing for infusion of various solutions at a rate of 20 µL/min [117, 118].
An isotonic saline solution containing 6% albumin (EMD Chemicals, Gibbstown, NJ) was
infused during surgery. After surgery, the infusion fluid was changed to isotonic saline
containing 2% bovine serum albumin (BSA), 7.5% inulin (Inutest), and 1.5% PAH. The bladder
was catheterized with a PE-90 tube (with one end flanged) via a suprapubic incision for
gravimetric urine collection. After a 15- to 20-minute stabilization period, a 30-minute clearance
period was conducted to assess values of renal hemodynamic parameters. An arterial blood
sample was collected at the end of the 30-minute clearance collection period for measurement of
plasma inulin and PAH concentrations. Plasma inulin and PAH concentrations were measured
colorimetrically to determine glomerular filtration rate (GFR) and renal plasma flow (RPF),
respectively. Renal blood flow (RBF) was calculated from RPF and hematocrit (Hct) using the
standard formula: RBF = RPF÷(1-Hct).
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Biochemical Assays for Urine and Plasma
Albumin in urine was quantified with a Nephrat II ELISA kit (Exocell, Philadelphia, PA)
and TNF-α, IL-6, and IL-1β were quantified in plasma samples with ELISA kits from
Biosource/Invitrogen (Carlsbad, CA). Creatinine and urea were quantified in plasma and urine
with QuantiChrom Creatinine and Urea Assay Kits (BioAssay Systems, Hayward, CA).
Blood urea nitrogen (BUN) levels and creatinine clearances (CCr) were calculated using
standard equations, which are: BUN = plasma urea÷2.14. Creatinine clearance (CCr) was
calculated using the following standard equation: CCr = (UCr x V) ÷ (PCr x tmin); where UCr = urine
creatinine, V = urine volume, PCr = plasma creatinine, and tmin = time of urine collection in
minutes. Time of urine collection was 24 hours for each animal.
Isolation of Mitochondria and Measurement of Mitochondrial Permeability Transition
Kidney mitochondria were isolated by differential centrifugation of renal cortical
homogenates and mitochondrial swelling was measured as described previously [104]. Briefly,
mitochondrial isolation buffer contained (in mmol/L): 140 D-mannitol, 75 sucrose, 1 EGTA, 10
MOPS; and 0.4% BSA, pH 7.4, and a mixture of protease inhibitors (Complete; Roche
Diagnostics, Mannheim, Germany). Mitochondrial protein concentration was determined using a
DC Protein Assay Kit (Bio-Rad, Hercules, CA).

Mitochondrial purity was determined by

western blot with an anti-voltage dependent anion channel (VDAC; a mitochondrial marker)
antibody (Santa Cruz Biotechnology), and by transmission electron microscopy (Figures 2.1A
and 2.1B).
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Figure 2.1. Mitochondrial purity as determined by (A) transmission electron microscopy and (B)
western blotting. Voltage-dependent anion channel (VDAC) was used as a mitochondrial
marker.
Measurement of NAD(P)H-Dependent Superoxide Anion Production
Lucigenin-enhanced chemiluminescence was used to measure NADPH oxidase activity
in kidney tissues according to the method of Li et al [119].
Determination of Catalase Activity
Catalase activity was measured by the method of Beers and Sizer, as previously described
[104, 120].
Determination of Glutathione Peroxidase Concentrations
Glutathione peroxidase concentrations were determined in cortex homogenates and in
isolated mitochondria by use of a commercially available kit, according to the manufacturer’s
protocol (Cayman Chemicals, Ann Arbor, MI).
Measurement of ATP Production
Rates of ATP production were quantified in cortical mitochondria using a commercially
available kit (BioVision, Mountain View, CA).
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Western Blotting and EMSA
Protein expression in kidney cortical tissue was analyzed by western blot as previously
described [116], using anti-p65, anti-p50, anti-IκBα, anti-pIκBα, anti-TNF-α, anti-IL-6, and antiIL-1β antibodies (Santa Cruz Biotechnology, Santa Cruz, CA Densitometry analyses were
performed with Image J software. All membranes were normalized to GAPDH. Data in all
western blot figures are expressed as the ratio of the protein density to that of GAPDH. NF-κB
p65 DNA binding activity was assessed by electrophoretic mobility shift assay (EMSA), as
previously described [121].
RNA Isolation and Real-Time RT-PCR
Total RNA extraction, cDNA synthesis, and real-time RT-PCR were performed as
previously described [116].
Immunofluorescence
Immunofluorescence detection of desmin, TNF-α, NOX2, and NOX4 was performed as
previously described [122], with minor modifications. For the detection of desmin, NOX2,
NOX4, and TNF, slides were incubated overnight at 4°C with a 1:100 dilution of goat polyclonal
anti-desmin (Dako North America, Carpenteria, CA), or rabbit polyclonal anti-NOX2, anti-NOX
4, or goat polyclonal anti-TNF (Santa Cruz Biotechnology). Lack of nonspecific staining was
confirmed using no primary antibody controls. Analyses of fluorescence intensities were
performed using NIH Image J software. In the Image J program, outer borders of glomeruli were
traced and immunofluorescence was measured only inside the borders drawn. This method
allowed for quantification of glomerular immunofluorescence only, and allowed us to exclude
tubules from our analyses.
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Electron Paramagnetic Resonance (EPR) Studies
All EPR measurements were performed with a BenchTop EPR spectrophotometer e-scan
R (Noxygen Science Transfer & Diagnostics GmbH, Elzach, Germany). Three different spin
probes were used for EPR studies. CMH was used to measure total tissue reactive oxygen
species (ROS) and superoxide (O2•-), and mitochondrial total ROS and O2•-; CPH was used for
measurement of tissue peroxynitrite (OONO-); and PPH was used for mitochondrial hydrogen
peroxide (H2O2) studies. In this EPR protocol, ‘total ROS’ represents all reactive oxygen
species; however, the major sources trapped by the spin trap used are superoxide, hydrogen
peroxide, and hydroxyl radical, with other species as minimal contributors. Small portions (1520 mg each) of kidney tissue from each animal were minced and placed into four wells of a 24well tissue culture plate containing 20μM KHB with DF and DETC. Tissue pieces were then
washed twice with the same buffer to remove any trace contamination, and incubated at 37oC
with specific spin probes for 30 minutes. The incubation of tissue was terminated by placing the
plate on ice. All tissue EPR experiments were conducted at 20°C in disposable capillary tubes as
previously described [123], under the following settings: center field g = 2.002; field sweep
9.000G; microwave power 20 mW; modulation amplitude 1.90 G; conversion time 10.24 ms;
time constant 81.92 ms; receiver gain 3.17

e+0003

.

Mitochondrial total ROS production

experiments were performed at 37°C under 20 mmHg of oxygen partial pressure. The setup of
the oxygen concentration in KHB was performed using Gas-Controller NOX-E.4-GC (Noxygen
Science Transfer & Diagnostics GmbH, Elzach, Germany). For mitochondrial O2•- production,
the values obtained from incubation with SOD and CMH were subtracted from the values
obtained from incubation with CMH only.
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Separate spin trap solutions were prepared by dissolving 2.2 mg of CMH, 2 mg of CPH,
or 2 mg of PPH in 1 ml KHB (20 mM, pH 7.4), prepared with 25 μM DF and 5 μM DETC. All
spin probes are non-toxic. CMH is a cyclic hydroxylamine which is a highly cell permeable spin
probe for the quantification of slow-released intracellular and mitochondrial ROS.

CPH is an

effective, partially cell permeable spin probe for the in vitro detection of ONOO- and other
radicals. The spin adduct is resistant to reduction by vitamin C and thiols [123, 124]. PPH is a
non-cell permeable spin probe for the detection of mitochondrial H2O2 production [125]. ROS
released by tissues and mitochondria react with these probes to form stable adducts which can be
measured using EPR spectroscopy.
Cortical tissues were incubated at 37oC with 6.6 μl of CMH (200 μM) for 30 minutes for
ROS measurement; CMH for 30 minutes, then 1.5 μl of PEG-SOD (50 U/μl) for an additional 30
minutes for O2•- measurement; or 30 μl of CPH (500 μM) for 30 minutes for OONOmeasurement.

Aliquots of incubated probe media were then taken in 50 μl disposable glass

capillary tubes (Noxygen Science Transfer and Diagnostics, Elzach, Germany) for determination
of total cortical ROS, O2•-, or OONO- production. Renal cortical mitochondria (approximately
4-6 μg protein) from each animal were probed with CMH for mitochondrial total ROS and O2•measurements and with PPH (500 µM) and catalase (50 U/ml) for H2O2 measurement.
Superoxide detection in mitochondria was confirmed by inhibition of the O2•- signal with 50
U/ml superoxide dismutase (SOD). After adequate mixing, 50 μl mitochondria were taken in
disposable glass capillary tubes. Mitochondrial total ROS, O2•-, or H2O2 production was detected
using EPR under the settings mentioned above.
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Statistical Analyses
Data were analyzed with GraphPad Prism 5 software. All data are presented as means ±
SEMs. One-way repeated measures ANOVA with a post-hoc Bonferroni procedure was used to
compare differences in blood pressure measurements; one-way ANOVA with a Bonferroni
procedure was used to assess renal parameters, EPR measurements, antioxidant activities, and
ATP production. Two-way ANOVA with a Bonferroni procedure was used in comparisons of
NAD(P)H oxidase-dependent superoxide production rates and mitochondrial swelling assays.
Results were considered significant when p<0.05.
Results
There were no significant differences in body weights, food intake, or water intake
among groups in this study. The average daily delivered dose of PDTC was ~85-105 mg/kg/day
in both groups. WKY rats had significantly lower MAP and SBP than SHR at baseline and study
end (Table 2.1). SHR+ PDTC animals had lower SBP than SHR by week 6, and these values
remained significantly lower than the values in SHR for the remainder of the study (Figure 2.2).

Table 2.1. Mean final body weights and mean baseline and ending arterial and systolic
pressures (MAP and SBP, respectively) of study groups.
Group
(n=6 each)
WKY

Final Body
Weight (g)
384.7±6.08

MAP-Baseline

MAP-Week 15

SBP-Baseline

SBP-Week 15

99.5±1.96*†

94.5±2.84*

121.8±4.62*†

120.2±10.14*

WKY+PDTC

392.3±5.99

99.0±3.40*†

99.9±0.83*

112.8±3.42*†

119.5±6.65*

SHR

375.3±5.95

141.2±6.16

168.9±7.94†

160.4±8.23

196.4±9.76†

SHR+PDTC

387.5±9.26

132.7±10.12*

105.0±1.13*

161.4±8.30

151.4±2.12*

Values are reported as means ± SEM.

*

p<0.05 vs. SHR; † p<0.05 vs. SHR+PDTC.
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Figure 2.2. Systolic blood pressure trends for each study group. Values are reported as means ±
SEM. * p<0.05 vs. SHR; † p<0.05 vs. SHR+PDTC.
Significant decreases in glomerular filtration rate (GFR) and renal blood flow (RBF)
were noted in SHR when compared to other groups. Creatinine clearances (CCr), which were
calculated to verify inulin clearance data, followed the same trend. Additionally, urine albumin,
plasma creatinine, and BUN were all significantly higher in SHR than in other groups. Mean
values for each parameter appear in Table 2.2.
Table 2.2. Mean values of selected urine and plasma parameters for each study group.
Groups
(n=6)

GFR
(ml/min/g KW)

RBF
(ml/min/g
KW)

Plasma Cr
(mmol/L)

BUN
(mmol/L)

UA
mmol/L/24
hr)

Alb/Cr

WKY

0.972±0.104*

9.70±0.791*

0.72±0.04*

16.74±1.13*

441.2±35.7*

0.320±0.022*

WKY+PDTC

1.020±0.049*

11.03±0.610*

0.49±0.13*

11.41±2.21*

345.2±25.7*

0.341±0.006*

SHR

0.641±0.043†

3.83±0.589†

1.71±0.24†

25.18±1.15†

925.6±33.3†

0.511±0.033†

SHR+PDTC

0.938±0.063*

7.70±0.804*

0.51±0.09*

16.78±0.86*

358.7±31.2*

0.334±0.029*

Values represented are means±SEM. *p<0.05 vs.SHR; †p<0.05 vs.SHR+PDTC.
Total ROS, O2•- , and OONO- tissue production rates and total ROS, O2•-, and H2O2
production rates in mitochondria, as determined by EPR, were all significantly higher in cortical
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tissues of untreated SHR than in WKY, WKY+PDTC, and SHR+PDTC animals (Table 2.3).
These results indicate that production rates of reactive oxygen and nitrogen species are higher in
both the kidney cortex tissue and the cortical mitochondria of the SHR than in the normotensive
WKY, and that PDTC attenuates these increases in production.

Further, peak values of

NAD(P)H-dependent O2•- production, as measured by lucigenin assay, were significantly higher
in the SHR group than in other groups (Figure 2.2).
Table 2.3. Mean production values for tissue total reactive oxygen species (ROS), superoxide
(O2•-), and peroxynitrite (OONO-) ; and for mitochondrial total ROS, O2•-, and hydrogen
peroxide (H2O2), as measured by EPR.
TISSUE
(µmol/mg protein/minute)
Groups (n=6)
WKY

MITOCHONDRIA
(nmol/mg protein/minute)

O2•-

Total ROS
0.2132±0.0375

*

OONO-

0.0103±0.0019

*

O2•-

Total ROS
*

0.00524±0.0101

0.4386±0.0305

*

H2O2
*

0.0411±0.014

0.0032±0.0001*

WKY+PDTC

0.1314±0.0329*

0.0206±0.0041*

0.00510±0.0157*

0.4981±0.0699*

0.0337±0.0124* 0.0031±0.0002*

SHR

0.4615±0.0779†

0.0925±0.0188†

0.01974±0.0392†

1.100±0.1246†

0.2505±0.0649† 0.0063±0.0005†

SHR+PDTC

0.2013±0.0318*

0.0193±0.0043*

0.00641±0.0444*

0.6385±0.0789*

0.0605±0.0166* 0.0041±0.0006*

Values represented are means±SEM. *p<0.05 vs.SHR; †p<0.05 vs.SHR+PDTC.
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Figure 2.3. NAD(P)H–dependent superoxide production in cortical tissues. * p<0.05 vs. SHR, †
p<0.05 vs. SHR+PDTC.
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Protein expression levels of desmin (Figure 2.4A), NOX4 (Figure 2.4B), and NOX2
(gp91phox; Figure 2.4C) were all significantly lower in WKY, WKY+PDTC, and SHR+PDTC
rats than in SHR; mRNA expression followed a similar trend (Table 2.4). Expression levels of
NF-κB p65, p50 and IκBα followed similar trends (Figure 2.5A). SHR also exhibited
significantly higher DNA binding activity of NF-κB p65 (Figure 2.5B).

Figure 2.4. Immunofluorescence staining and luminometric analysis for glomerular desmin (A),
NAD(P)H oxidase (NOX)2 (gp91phox; B), and NOX4 (C).
Table 2.4. Gene expression values of desmin, NOX homologs, cytokines, IκBα, and NF-κB p65
in cortical tissues of WKY and SHR animals after 15 weeks of PDTC treatment.
Gene
Desmin
NOX2
NOX4
TNFα
IL-1β
IL-6
IκBα
NF-κB p65

WKY+PDTC
0.839±0.258*
0.716±0.024*
0.814±0.356*
0.695±0.050*
0.893±0.025
0.403±0.014*†
1.261±0.080*
0.785±0.148*†

SHR
1.737±0.111
3.428±0.693
2.970±0.291
2.901±0.985
1.091±0.125
1.834±0.183
0.372±0.080
1.451±0.084

SHR+PDTC
0.333±0.223*
0.251±0.666*
0.494±0.151*
1.038±0.147*
0.873±0.416
0.638±0.030*
1.381±0.197*
0.112±0.022*

Values are expressed as mean ± SEM fold change (2-ΔΔCt) vs. WKY control. *p<0.05 vs. SHR;
†
p<0.05 vs. SHR+PDTC.
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Figure 2.5. Representative western blots for NF- B p65, p50, I B , and GAPDH (housekeeping)
in cortical tissues (A) and EMSA for NF-κB p65 DNA binding activity (B). *P < 0.05 vs. SHR;
P < 0.05 vs. SHR+PDTC.
SHR exhibited significantly lower activities of tissue antioxidant levels of catalase and
glutathione peroxidase and lower mitochondrial glutathione peroxidase activity (Figure 2.6A),
along with significantly decreased ATP production (indicative of electron transport chain
damage) (Figure 2.6B). Plasma levels of IL-6 and TNF-α, but not IL-1β, were significantly
higher in SHR than in other animals (Figure 2.7A); protein and mRNA expressions of these
cytokines followed a similar trend (Table 2.4; Figures 2.7B-2.7D). Increased mitochondrial
swelling (indicative of mitochondrial membrane damage) was also observed in SHR (Figure 2.8).
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Figure 2.6. Mean enzyme activities for tissue and mitochondrial glutathione peroxidase (GPx)
and tissue catalase (A) and mean ATP production rates in experimental groups (B). * p<0.05 vs.
SHR, † p<0.05 vs. SHR+PDTC.
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Figure 2.7. Mean plasma cytokine levels (A) and cytokine protein expression levels (B, C) for
all study groups. Representative western blots and densitometric analyses for IL-6 and IL-1β
appear in (B). Immunofluorescence staining and luminometric analysis for glomerular TNFappear in (C). Scale bars = 50 µm. *P < 0.05 vs. SHR. P < 0.05 vs. SHR+PDTC.

B.

0.00

WKY
WKY+PDTC
SHR
SHR+PDTC

*
*

A5 4 0

-0.02

*

*

*

†

-0.04

*

*

*

*

*

*
*

-0.06
-0.08

*

*
*

* *
*

-0.00
-0.02
-0.04

A5 4 0

A.

-0.06
* *

-0.08

*

-0.10
*

*

*
*

*
*

* *

*

*

*

*

*

*

*

-0.12
-0.14

0

5

10

15

0

Minutes

5

10

15

Minutes

Figure 2.8. (A) Mean basal optical density (OD) and (B) mean OD with 50mM calcium added
for mitochondrial swelling assay. * p<0.05 vs. SHR, † p<0.05 vs. SHR+PDTC.
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Discussion
In this study, we examined the effects of chronic NF-κB blockade with PDTC on cortical
tissue and mitochondrial ROS production in the hypertensive kidney. The salient findings of the
present study are: 1) cytosolic and mitochondrial oxidative stress, caused by up-regulation of
NF-κB and NF-κB-induced PIC, contribute to renal damage and hypertension in SHR; and 2)
NF-κB blockade partially attenuates blood pressure, and normalizes renal function parameters
and cytosolic and mitochondrial redox status in SHR. These data suggest that NF-κB plays a
role in hypertensive injury in renal cortical tissue and mitochondria by increasing production of
PIC and ROS, and that long-term NF-κB blockade can ameliorate these detrimental effects.
We found significant decreases in MAP and SBP in SHR+PDTC rats when compared
with untreated SHR, and saw no change in MAP or SBP in WKY treated with PDTC. PDTC
treatment also improved GFR, RBF, plasma creatinine levels and BUN, and urinary albumin
levels in SHR. Other researchers have used PDTC in hypertensive rat models, and have found
similar improvements in blood pressure and end organ damage [112, 126, 127].
Renal and vascular oxidative stress are known to accompany hypertension in the SHR
[128]. Increased ROS production, the exact cause of which remains unknown, is thought to be
both a cause and a consequence of hypertension [111]. A number of mediators of this oxidative
stress have been identified, including PIC (such as TNF-α and IL-6) and angiotensin II (ANGII);
both can degrade IκBα to cause NF-κB activation and further increase ROS production. PDTC
is believed to exert its inhibitory effects on NF-κB by directly impeding IκBα degradation[129].
PDTC treatment in SHR attenuated the up-regulation of protein and mRNA expression of
desmin (a marker of glomerular injury). Desmin expression in most rat strains is confined to
mesangial cells; podocytes only express desmin following injury [130]. ROS are known to alter
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several signaling cascades in podocytes [131]. Further, NF-ĸB activation has been shown to
upregulate ROS-induced inflammation in mouse podocytes [132]. This evidence, along with our
current findings, suggests a critical role for NF-κB in glomerular epithelial injury. NAD(P)H
oxidase is the predominant source of ROS production in the renal cortex, and the predominant
NOX isoform expressed in the kidney cortex is NOX4 [133].

PDTC administration also

attenuated protein and mRNA expression of NOX2 (gp91phox) and NOX4 in glomeruli.
NAD(P)H-dependent O2•- production was also decreased in the cortical tissues of PDTC-treated
SHR.

Taken together, these results suggest that NF-κB-mediated activation of NAD(P)H

oxidases, and of desmin, contributes at both the transcriptional and translational levels to the
renal damage seen in SHR.
Both mitochondria and NAD(P)H oxidases are important sources of ROS in cells.
NAD(P)H oxidases are activated and upregulated in SHR prior to the onset of hypertension in
this model [103]. Although O2•- from NAD(P)H oxidases is considered the major player in
glomerular injury, the possible contributory role of mitochondrial ROS in perpetuating renal
dysfunction in hypertension cannot be ignored. Recently, Doughan et al [134] demonstrated that
the full enzymatic activity of NAD(P)H oxidase was required for ANGII-induced mitochondrial
damage. Also in that study, NAD(P)H oxidase blockade with apocynin was shown to attenuate
ANGII-induced mitochondrial damage in endothelial cells [134].

The same effects on

mitochondrial dysfunction were also seen in a study by De Cavanaugh et al, which demonstrated
decreased mitochondrial oxidant production and improved mitochondrial membrane potential in
SHR with angiotensin II receptor blockade [135]. These results suggest that NAD(P)H oxidasedependent O2•- can act as an upstream signal to cause increased mitochondrial O2•- production.
This mitochondrial O2•-, along with H2O2 which can diffuse out of the mitochondrion, can then
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act to further stimulate NAD(P)H activation in a feed-forward mechanism.

Further, O2•-

produced from NAD(P)H oxidases can activate NF-ĸB either directly, or indirectly through an
increase in mitochondrial ROS production; however, further studies are needed to elucidate the
degree of involvement of both mitochondria and NAD(P)H oxidases in the activation of this
ROS-dependent transcription factor.
Until now, no studies have examined the effect of NF-κB blockade on mitochondrial
functionality in the hypertensive kidney. We employed EPR, a reliable and sensitive method of
measuring and quantifying ROS production, to analyze production of various ROS in both tissue
and isolated mitochondria of experimental animals. As expected, PDTC treatment decreased
production of total ROS, O2•-, and OONO- as determined by EPR in the renal cortical tissue of
SHR, thereby signifying the role of NF-κB in tissue ROS production.
Mitochondrial total ROS, O2•-, and H2O2 production rates were all significantly lower in
PDTC-treated SHR.

Mitochondrial membrane integrity and ATP production rates were also

significantly improved in PDTC-treated SHR. Hypertension is associated with mitochondrial
dysfunction in several tissues including the heart and kidney [97, 135]. ROS generated by the
mitochondrial electron transport chain (ETC) may act as second messengers to the activation of
NF-κB by cytokines such as TNF-α [136]. Also, cells lacking functional mitochondrial ETC
show significant down-regulation of NF-κB activation [137], thus reinforcing

a role for

mitochondrial ROS in activation of NF-κB. However, some caution must be used in interpreting
these results, as isolated mitochondria were used.

Further studies should employ in vivo

mitochondrial blockade and ROS measurement; results from these procedures would allow us to
provide more representative data in regard to the function of mitochondrial ROS in the
hypertensive kidney as a whole.
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NAD(P)H-dependent O2•- and other cytoplasmic ROS can also activate NF-κB, causing a
further increase in ROS production, which leads to increased mitochondrial ROS production and
further perpetuates this vicious positive feedback cycle. In this study, increased activity and
expression of NF-κB and the cytokines TNF-α and IL-6 were associated with increased tissue
ROS production (especially that of O2•-), as determined by EPR and lucigenin assay. Increased
NF-κB and PIC expression were also associated with increased mitochondrial ROS production
and decreased ATP production, both of which suggest a contributory role for mitochondrial
dysfunction in hypertensive renal injury. Decreased ATP production is an indicator of ETC
dysfunction, as is increased mitochondrial ROS production; damage to the ETC results in free
radical leakage, thereby perpetuating mitochondrial damage and ROS production. Chronic NFκB blockade with PDTC may have attenuated increases in ROS by partially inhibiting the
positive feedback between mitochondrial and cytosolic ROS, NF-κB, and NF-κB-regulated PIC
in the hypertensive kidney.
Superoxide generated by the mitochondrial ETC can be converted to H2O2 in the
mitochondrial matrix or in the intermembrane space. H2O2 can be detoxified to water by
mitochondrial glutathione peroxidase, or to water and oxygen by catalase. These enzymes
comprise a complex mitochondrial defense system that is critical in ROS detoxification. In this
study, SHR exhibited lower activities of catalase and glutathione peroxidase, and an increased
H2O2 production rate, as measured by EPR, indicating the impairment of the mitochondrial
antioxidant defense system in the presence of increased NF-κB activity. Long-term NF-κB
blockade with PDTC restored the activities of these antioxidant enzymes to near control levels in
SHR.

These results suggest that impairment of mitochondrial antioxidants, combined with
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overproduction of mitochondrial ROS, could contribute to the mitochondrial damage seen in
hypertensive renal injury.
This study provides a first glance at the role of NF-κB in mitochondrial ROS production
in the hypertensive rat kidney. Although this study is the first to quantify mitochondrial ROS in
the kidney cortex in the presence or absence of NF-κB blockade, some limitations exist. First,
our results suggest an obvious role for mitochondrial ROS in renal injury, but they do not allow
us to determine the exact source of mitochondrial ROS overproduction, or the degree of
involvement of mitochondrial ROS, since mitochondrial inhibitors were not used. Second, we
cannot exclude the possibility that the antioxidant properties of PDTC are also involved in the
reduction of ROS production in our study. Lastly, there was a significant decrease in SBP
(196.4±9.76 vs. 151.4±2.12) with PDTC treatment; this also could have altered the
antioxidant/oxidant parameters measured in this study, thereby contributing to the beneficial
effects seen with PDTC. However, the EMSA results and mRNA and protein expression data
showing decreased IκBα and increased p65 and p50 in SHR kidney cortex suggest that direct
inhibition of NF-κB is responsible, at least in part, for the beneficial effects seen in this study. In
an extension of this study that is currently ongoing, we are using mitochondrial inhibitors; this
will allow us to better define the role of the mitochondrion in contributing to renal abnormalities
in SHR.
In conclusion, the results of the present investigation support a possible role for
mitochondrial ROS in hypertensive renal injury (in addition to cytosolic ROS), and suggest that
NF-κB-induced PIC negatively affect mitochondrial and tissue ROS production in the
hypertensive renal cortex. Successful prevention of renal damage should therefore involve
therapies that not only inhibit cytokine-induced NF-κB activation, but also offer mitochondrial
46

protection from NF-κB-induced PIC and ROS production. Future research should focus on the
precise signaling mechanisms by which NF-κB-induced PIC and ROS and mitochondrial ROS
interact in the kidney in the setting of essential hypertension.
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CHAPTER 3
CHRONIC EXERCISE PRESERVES RENAL STRUCTURE AND HEMODYNAMICS
IN SPONTANEOUSLY HYPERTENSIVE RATS
Introduction
Hypertension-induced renal dysfunction is a significant cause of morbidity and mortality
in hypertensive patients, and remains a leading cause of end-stage renal disease in the United
States [138]. Current anti-hypertensive treatments are mostly effective in reducing the severity of
hypertensive renal disease; however, its progressive clinical course underscores the need for new
therapeutic approaches. The benefits of non-pharmacological interventions, such as diet and
exercise, on several chronic diseases are well-established. To date, no detailed reports exist that
examine the effects of exercise training (ExT) on renal redox status, renal hemodynamics, or
renal structure in the hypertensive condition. Therefore, we chose to examine the effects of ExT
on renal function and injury and also examined ExT-induced changes in oxidative, nitrosative,
and inflammatory parameters in the spontaneously hypertensive rat (SHR), a genetically
hypertensive rat model that exhibits many features of human essential hypertension.
We and others have demonstrated that proinflammatory cytokine (PIC) production and
several renin-angiotensin system (RAS) components are increased in the hypertensive kidney
[139-141]. Reactive oxygen species (ROS) production is also increased in the renal tissue of the
SHR. Further, PICs and RAS components have been found to increase ROS production [142144], which in turn can activate various intracellular signaling pathways, including that of the
transcription factor nuclear factor-kappa B (NF-κB) [139]. Activation of NF-κB induces
transcription of PIC genes, leading to further increases in ROS production and fostering a cyclic
positive feedback mechanism, thereby accelerating the progression of hypertension and its
associated renal changes.
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Several previous studies have investigated the effects of exercise on hypertension and
kidney diseases; however, most of the studies were performed on patients or animals with
established disease or the exercise was combined with other interventions [145-149]. However,
the effects of ExT on delaying or preventing the progression of hypertension-induced renal
injury have not yet been elucidated. The mechanisms by which chronic ExT may affect renal
function are unknown, although various mechanisms have been proposed, which include a direct
lowering of blood pressure, leading to reduced peripheral vascular resistance [150] and
reductions in oxidative stress [149]. Here, we hypothesized that chronic ExT would preserve
renal structure and function by modulating oxidative stress and inflammation in the SHR model
of hypertension.
Materials and Methods
All procedures in this study were approved by the Louisiana State University Institutional
Animal Care and Use Committee and were performed in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals.
Animals and Experimental Design
Seven-week-old

male

normotensive

Wistar-Kyoto

(WKY)

and

spontaneously

hypertensive rats (SHR), from colonies maintained at the Louisiana State University School of
Veterinary Medicine, were used in this study. The original source of the breeder animals was
Harlan (Indianapolis, IN). Prior to the initiation of any experimental protocols, five WKY and
five SHR were subjected to acute renal clearance experiments as previously published, to obtain
baseline values for glomerular filtration rate (GFR) and renal plasma flow (RPF) [139]; animals
were euthanized by thiobutabarbital overdose immediately following clearance experiments.
Four groups of eight animals each were used for the experimental protocol: sedentary WKY
(WKY-S), sedentary SHR (SHR-S), exercise WKY (WKY-E), and exercise SHR (SHR-E).
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Animals in exercise groups were subjected to moderate-intensity exercise on a motor-driven
treadmill for a period of 16 weeks (5 days per week; 60 min per day at 18 m/min, 0o inclination)
which includes an acclimation period of 2 weeks. After acclimation, training intensity was set at
approximately 60% of maximal aerobic velocity, which corresponds to moderate intensity
exercise (18-20m/min). This protocol is established in our lab and has been used in previous
studies .
At the end of the study, six animals from each experimental group were anesthetized and
subjected to acute renal clearance experiments [139]. Animals in the exercise groups were
sacrificed 24 hours after the last exercise session (at age 24 weeks); sedentary animals were
sacrificed at the same age. Animals were euthanized immediately after clearance experiments
and kidneys were excised; one kidney from each animal was sectioned, with unstained sections
being used for immunofluorescence studies and stained sections being used for histopathological
examination. Cortical tissue was separated from the other kidney and stored for later analyses.
We performed the following experimental procedures as previously described in Chapter 2: realtime

RT-PCR,

western

blot,

electron

paramagnetic

resonance

(EPR)

studies,

immunofluorescence, antioxidant assays, and statistical analysis. A NF-ĸB p65 DNA binding
assay was also performed, using an assay kit from Active Motif, as previously described [151].
Renal Clearance Experiments
Acute renal clearance experiments were performed according to previously published
methods [139].
Glomerular Injury Scoring
For light microscopy, renal tissues were fixed with formalin, embedded in paraffin, cut
into 4-5 um sections, and stained with periodic acid-Schiff reagent. All tissue sections were
evaluated by a veterinary pathologist that was blinded to experimental conditions. A semi54

quantitative glomerular lesion scoring method was used, which was based upon previously
published methods for glomerulosclerosis scoring [152] and expanded to include the following
criteria: tubular epithelial metaplasia of Bowman’s capsule, glomerulosclerosis, mesangial
proliferation, and glomerular capillary basement membrane thickening.

Since it is well-

accepted that tubular metaplasia is the first evidence of glomerular structural alteration in SHR
[153], this was the primary lesion used in our scoring system. One hundred glomeruli in each
section were examined and severity of each glomerular lesion was graded from 0 to 4 according
to the percentage of glomerular involvement; 0 = no sign of tubular metaplasia, +l = 0 to 25% of
glomerulus exhibiting tubular metaplasia, +2 = 25 to 50% of glomerulus exhibiting tubular
metaplasia, +3 = 50 to 75% of glomerulus exhibiting tubular metaplasia, and +4 = 75 to 100% of
glomerulus exhibiting tubular metaplasia. For each specimen, the grade of the lesion severity
determined in this manner was totaled, giving rise to a glomerulosclerosis score for each section
examined, which ranges 0 to 400.
Measurement of Cortical Nitrate/Nitrite Production
The reaction of nitric oxide (NO) with oxygen can cause the oxidation of NO, leading to
nitrate/nitrite production; therefore, levels of nitrate/nitrite are considered an indirect indicator of
NO production. Nitrate/nitrite levels were measured in renal cortical tissues of animals from all
experimental groups with a commercially available colorimetric assay kit (Cayman Chemical;
Ann Arbor, MI), as previously described [151].
Measurement of Cortical NF-κB p65 DNA Binding Activity
Activated NF-ĸB translocates to the nucleus, where the p65 subunit binds to DNA to
promote transcription. The binding activity of free NF-κB p65 in nuclear extracts was assessed
with a NF-κB p65 TransAM ELISA kit (Active Motif, Carlsbad, CA) as per manufacturer’s
instructions, as previously described [154].
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Measurement of Cortical Glutathione and Glutathione Peroxidase Levels
Antioxidant status was assessed in renal cortical tissues of animals from all groups by
measurement of reduced and oxidized glutathione and glutathione peroxidase, with
commercially available colorimetric assay kits (Cayman Chemical, Ann Arbor, MI), as
previously described [144].
Analysis of mRNA Expression by Real-Time PCR
Total RNA isolation from renal cortical tissues, cDNA synthesis and real-time RT-PCR
were performed as previously described in detail [139, 151].
Analysis of Protein Expression by Western Blotting
Protein expression in renal cortical tissues was determined by western blot analysis as
described previously in detail [139, 151].
Electron Paramagnetic Resonance Spectroscopy
Total ROS, superoxide, and peroxynitrite were measured in renal cortical tissues using
electron paramagnetic resonance spectroscopy as described previously in detail [139, 144, 155,
156]. In this EPR protocol, ‘total ROS’ represents all reactive oxygen species; however, the
major sources trapped by the spin trap used are superoxide, hydrogen peroxide, and hydroxyl
radical, with other species as minimal contributors.
Immunofluorescence
Immunofluorescence detection of 3-nitrotyrosine (Cayman Chemical, Ann Arbor, MI;
1:100 dilution) in paraffin-embedded kidney sections was conducted as previously described
[139].
Statistical Analyses
All data are presented as means ± SEM. For baseline analyses between WKY and SHR,
Student’s t-tests were used. At study completion, Student’s t-tests were used to execute planned
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comparisons between WKY-S and SHR-S; WKY-E and SHR-E; and SHR-S and SHR-E groups.
In all cases, results were considered significant when p<0.05.
Results
Body Weights
There were no significant differences in body weights between WKY and SHR groups at
baseline (Table 3.1). However, body weights were significantly lower in both WKY and SHR
exercise groups at study end when compared to their sedentary counterparts (Table 3.2).
ExT Preserves Renal Hemodynamics in SHR
No differences in systolic blood pressure (SBP) or mean arterial pressure (MAP) were
noted between WKY and SHR at baseline (Table 3.1). At study end, the pressures for SHR-E
animals were significantly lower than those for SHR-S animals (Table 3.2). There were also no
differences observed in GFR, RBF, or renal vascular resistance (RVR) between the WKY and
SHR groups at baseline (Table 3.1). Lower GFR and RBF values and higher RVR values were
found in SHR-S rats when compared to SHR-E rats at study end (Table 3.2). There were no
significant differences in GFR, RBF, or RVR values between WKY-S and WKY-E animals or
between SHR-S and SHR-E animals.
Table 3.1. Baseline hemodynamic data for WKY and SHR (obtained at 7 weeks of age).
WKY (n=5)

SHR (n=5)

BW (g)

193.9 ± 1.61

189.4 ± 2.83

SBP (mmHg)

120.6 ± 3.32

124.7 ± 1.99

MAP (mmHg

106.3 ± 2.94

106.8 ± 2.12

GFR (ml/min/g KW)

1.01 ± 0.04

0.94 ± 0.05

RBF (ml/min/g KW)

6.97 ± 0.33

6.25 ± 0.77

RVR (mmHg/ml/min/g KW)

11.41 ± 1.01

14.89 ± 0.51

Data are presented as mean ± SEM.
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Table 3.2. Mean body weights and hemodynamic measurements from rats from all groups
(obtained at study conclusion).
Parameter
BW (g)

WKY-S
(n=6)
372.4 ± 4.61

WKY-E
(n=6)
323.0 ± 7.64$

SHR-S
(n=6)
370.8 ± 2.63†

SHR-E
(n=6)
314.4 ± 11.69*

SBP (mmHg)

121.1 ± 2.37*

130.7 ± 2.36

189.2 ± 3.47†$

144.8 ± 3.50*

MAP (mmHg)

93.9 ± 1.83*

98.6 ± 2.21

163.4 ± 9.30†$

120.0 ± 4.73*

GFR (ml/min/g KW)

0.90 ± 0.09*

0.90 ± 0.05

0.45 ± 0.08†$

0.73 ± 0.05*

RBF (ml/min/g KW)

8.26 ± 1.11*

7.24 ± 0.79

3.58 ± 0.45†$

7.51 ±0.58*

RVR
(mmHg/ml/min/g KW)

13.61 ± 1.61*

16.22 ± 0.49

42.49 ± 7.81†$

15.96 ± 2.84*

*

p<0.05 vs. SHR-S; † p<0.05 vs. SHR-E; $ p<0.05 vs. WKY-S.

ExT Preserves Glomerular Morphology in the SHR Kidney
PAS-stained kidney sections from rats (n=5 from each group) were examined at the end
of the study by a veterinary pathologist who was blinded to the experimental conditions. One
hundred glomeruli from each section were scored.

Representative photomicrographs of

glomeruli for each lesion score appear in Figures 3.1A – 3.1E. There was no significant
difference in glomerular lesion scores for WKY or SHR at baseline (WKY score 27 ± 1.44 and
SHR score 34 ± 2.61). SHR-S rats had significantly higher glomerular lesion scores than WKYS and SHR-E rats at the completion of the study (Figure 3.1F). No differences in scores were
found between WKY-S and WKY-E rats.
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Figure 3.1. Representative photomicrographs for scoring of glomerular injury at study
completion. Scale bars = 50 μm. A) Grade 0 – glomerulus with no lesions; B) Grade 1 – 0-25%
of glomerular area affected; C) Grade 2 – 25-50% of glomerular area affected; D) Grade 3 – 5075% of glomerular area affected; E) Grade 4 – 75-100% of glomerular area affected. F) Average
glomerular lesion scores for each experimental group (n=5 animals per group). * p<0.01; **
p<0.05; ***p<0.001.

ExT Decreases Total ROS and Superoxide Production in the SHR Kidney
We measured total ROS and superoxide production rates using EPR spectroscopy in
cortical tissues from rats (n=6 per group) in all experimental groups. Production rates of both
species were significantly decreased in cortical tissues of SHR-E rats when compared to SHR-S
rats (Figures 3.2A and 3.2B). Significant differences in total ROS measurements were found
between WKY-S and WKY-E rats, but not between WKY-E or SHR-E rats. No significant
differences superoxide measurements were found between WKY-S and WKY-E rats or between
WKY-E and SHR-E rats.
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ExT Decreases Peroxynitrite Production and NT Formation in the SHR Kidney
We measured cortical peroxynitrite levels in all rat groups (n=6 per group) using EPR
spectroscopy. We also examined expression of 3-nitrotyrosine (NT), a footprint of peroxynitrite
formation, via immunofluoresence. In the SHR-E rats, peroxynitrite production rates were
significantly decreased and NT expression levels were lower when compared to those of SHR-S
rats (Figures 3.2C and 3.2D, respectively).

Figure 3.2. Free radical production rates as determined by electron paramagnetic resonance
spectroscopy, and immunofluorescence staining for 3-nitrotyrosine. A) Total reactive oxygen
species (ROS), B) superoxide, and C) peroxynitrite production rates in renal cortical tissues of
rats from each experimental group, D) Immunofluorescence for 3-nitrotyrosine, an indirect
indicator of peroxynitrite formation. * p<0.01; ** p<0.05; ***p<0.001.
60

ExT Improves Antioxidant Status in the SHR Kidney
We measured glutathione peroxidase (GPx) and reduced and oxidized glutathione (GSH
and GSSG, respectively) in cortical tissues from each experimental group (n=5 per group), using
commercially available kits. Levels of GPx and both GSH and GSSG were significantly lower
in SHR-S animals than in any other group (Figures 3.3A-3.3D). Exercise treatment increased
GPx, GSH, and GSSG levels in SHR animals.

Figure 3.3. Levels of reduced glutathione (GSH; A) and oxidized glutathione (GSSG; B),
GSH/GSSG ratio (C), and glutathione peroxidase (GPx; D) as measured in cortical tissues.
* p<0.01; ** p<0.05; ***p<0.001.
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ExT Decreases NF-κB Activity and TNF-α Expression in the SHR Kidney
Renal cortical NF-κB p65 DNA binding activity was measured in tissues from all groups
(n=6 per group). Rats from the SHR-S group had significantly higher cortical NF-κB activity
than WKY-S rats (Figure 3.4A). The SHR-E rats had NF-κB activity levels comparable to the
WKY-S and WKY-E rats, suggesting that chronic ExT prevents the increase in cortical NF-κB
activity seen in SHR. Since the proinflammatory cytokine tumor necrosis factor-alpha (TNF-α)
acts through a NF-κB-dependent pathway, we measured protein and gene expression of this
cytokine in the cortical tissues of animals from all experimental groups. Expression of TNF-α
was significantly increased in SHR-S rats, but was completely normalized in SHR-E rats
(Figures 3.4B and 3.4C).

Figure 3.4. NF-κB p65 DNA binding activity (A) and protein (B) and mRNA (C) expression
levels of TNF-α in renal cortical tissues. * p<0.01; ** p<0.05; ***p<0.001.
ExT Alters NO Production and NOS Isoform Expression in the SHR Kidney
Protein and gene expression levels of eNOS and iNOS were measured in all experimental
groups at study completion (Figures 3.5A and 3.5B, respectively). Cortical nitrate/nitrite levels
(indirect indicator of NO production) were also measured (Figure 3.5C). Both protein and gene
expression levels of eNOS, along with NO production, were decreased in SHR-S rats, while
iNOS levels were significantly increased. These effects were normalized in the SHR-E animals.
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ExT Alters Expression of RAS Components in the SHR Kidney
Protein (Figure 3.6A) and gene expression (Figure 3.6B) levels of ACE, ACE2, AT-1
receptor (AT-1R), and Mas receptor (MasR) were measured in all experimental groups at study
completion. Circulating AngII levels were also measured in plasma samples from animals from
all experimental groups at study end (Figure 3.6C). Both protein and gene expression levels of
ACE and AT-1R were higher in SHR-S rats, while ACE2 and MasR levels were significantly
lower. Similarly, AngII levels were also elevated in SHR-S animals. In SHR-E animals, ACE2
and MasR expression levels were elevated, while ACE and AT-1R expression levels were
decreased. Circulating AngII levels were also lower in SHR-E animals.

Figure 3.5. Protein (A) and mRNA expression (B) of eNOS and iNOS, and NO production (C)
as assessed by nitrate/nitrite measurement, in kidney cortical tissues from each group. *p<0.01;
** p<0.05; ***p<0.001.
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Figure 3.6. A) Protein and B) mRNA expression of various renin-angiotensin system
components and C) mean plasma ANGII levels. * p<0.01; ** p<0.05; ***p<0.001.

Discussion
Primary (essential) hypertension remains a major cause of morbidity and mortality in
Western society, and is the second leading cause of end-stage renal disease in the United States
[157]. The most effective way to avoid the development of hypertension-induced renal injury is
to prevent hypertension or to delay its progression. Current pharmacological therapies have
proven beneficial in the treatment of hypertension, but the focus has recently shifted to include
non-pharmacological approaches, such as exercise, as adjunct therapies to prevent or mitigate
hypertension and its end-organ effects. Here, we examined the effects of ExT on renal function
and injury and assessed exercise-induced changes in oxidative, nitrosative, and inflammatory
parameters in SHR. We initiated chronic ExT at 7 weeks of age, an age when SHR are still
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normotensive and have normal renal hemodynamic indices.

We also performed baseline

measurements of arterial pressures and renal hemodynamic parameters in 7-week old WKY and
age-matched SHR, with no statistically significant differences found between strains for any of
the parameters measured (Table 1). Results from our endpoint studies demonstrate that chronic,
moderate-intensity ExT prevents renal oxidative stress and inflammation, maintains renal
antioxidant defense, and modulates both intrarenal and extrarenal renin-angiotensin system
components in SHR. Chronic exercise also resulted in a delayed increase in body weight,
prevented the development of severe hypertension, and preserved renal structure and renal
hemodynamics in these animals.
Oxidative stress is characteristic of the adult SHR, and has been shown to precede the
development of hypertension in this rat strain by several weeks [158, 159]. Conversely,
hypertension has been shown to cause oxidative stress in the kidney [160].

This self-

perpetuating cycle, if left unchecked, can lead to progressive renal disease. Several key
mediators of renal oxidative stress have been identified, including PIC and the effector peptide of
the renin-angiotensin system, AngII; both can cause activation of the key redox-sensitive
transcription factor, NF-κB, and increase production of ROS and reactive nitrogen species
(RNS), such as superoxide and peroxynitrite, respectively. These ROS/RNS themselves can
increase NF-κB activity, leading to further oxidative/nitrosative insult and RAS activation, which
perpetuates this vicious positive feedback cycle and accelerates hypertension-induced renal
damage [139]. A schematic representation of this cycle appears in Figure 3.7.
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Figure 3.7. Schematic depiction of the interactions of oxidative stress, inflammation, RAS
activation, and NO imbalance in the pathogenesis of hypertensive renal injury, and the effects of
exercise training on this vicious positive feedback cycle.
NF-ĸB can induce and respond to oxidative stress; when activated, NF-ĸB can activate
the promoters of two proinflammatory molecules - TNF-α [161] and iNOS [162]. A key finding
in the present study is that NF-ĸB p65 DNA binding activity, along with cortical protein and
gene expression levels of iNOS and TNF-α, did not increase in the SHR kidney when ExT was
initiated prior to development of hypertension, while all three parameters increased significantly
in sedentary SHR. Conversely, gene and protein expression levels of eNOS were significantly
higher in SHR-E animals then in SHR-S animals. Further, chronic ExT prevented the increases
normally seen in cortical total ROS, superoxide, and peroxynitrite production rates in SHR. Our
current finding that decreased oxidative stress is associated with decreased TNF-α expression and
decreased NF-ĸB activity in SHR-E rats raises the possibility that decreased PICs might be
responsible for the exercise-induced decrease in oxidative stress in SHR.
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Oxidative stress, by definition, involves an excess of free radicals; in the case of renal
oxidative stress during hypertension, the predominant free radical is superoxide, which is mostly
produced by NADPH oxidases [163]. We have previously demonstrated an up-regulation in
NADPH oxidase expression and activity in the cortical tissues of SHR; this was associated with
a decline in renal hemodynamic parameters and with increased arterial pressure [139]. In
addition to its direct detrimental effects, superoxide can interact with NO to form the highly
cytotoxic peroxynitrite radical.

Peroxynitrite can then react with tyrosine residues in various

proteins to generate NT [164, 165]. Although NT can be formed from reactions that do not
include NO [166], the contribution of these reactions to total tissue NT abundance is minimal;
thus, tissue NT abundance is largely considered a function of the interaction between superoxide
and NO [164]. In this study, the increase in arterial blood pressure and alterations in renal
hemodynamics seen in sedentary SHR were accompanied by cortical accumulation of NT and
increased tissue production rates of total ROS, superoxide, and peroxynitrite. These findings
were also accompanied by a marked reduction in renal cortical NO metabolites, which is
suggestive of diminished NO bioavailability, likely resulting from an enhancement of NO
inactivation by superoxide. We also found decreased GPx and GSH levels and decreased
GSH/GSSG ratio in cortical tissues of SHR-S animals, which is indicative of insufficient
antioxidant status. Lee and colleagues recently found similar impairments in the glutathione
system in SHR from the age of 8 weeks [167]; our results suggest that this impairment continues
through age 24 weeks, and that ExT prevents these alterations in antioxidant status.
In exercised SHR, there was a delayed, moderate increase in arterial pressure and a
normalization of cortical NO metabolites. Further, SHR-E exhibited no evidence of cortical NT
accumulation and no appreciable increases in tissue production rates of total ROS, superoxide, or
peroxynitrite. These results were associated with a preservation of renal hemodynamics and
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renal antioxidant status in these animals, and with alterations in cortical gene and protein
expression levels of iNOS and eNOS.

Our results are in line with a previous report from our

lab, where the same ExT regimen resulted in preserved cardiac function, decreased ROS
formation, decreased iNOS expression, and increased NO metabolites in the SHR myocardium
[151]. Taken together, these observations suggest that chronic ExT can decrease the severity of
hypertension and its associated alterations in renal hemodynamics in SHR by ameliorating the
renal oxidative stress known to exist in these animals. These beneficial effects seem to involve
preservation of redox status and an improvement in NO bioavailability.
Activation of the RAS and the resulting AngII-induced pressor response are key
mediators of renal damage [168, 169], and have renal pro-oxidant and proinflammatory effects
which negatively alter renal hemodynamic parameters [168, 170]. For example, AngII can
antagonize the effects of NO [171], potentiate superoxide production [170], and activate NF-ĸB
[172]; these actions of AngII represent another arm of the vicious positive feedback cycle
involved in hypertension-induced renal injury. We measured protein and gene expression levels
of several RAS components (AT-1R, ACE, ACE2, and MasR) and circulating AngII levels to
assess the possible involvement of the RAS in the renoprotection afforded by ExT in this study.
We found down-regulation of AT-1R and ACE and decreased plasma AngII, with concomitant
up-regulation of ACE2 and MasR, in exercised SHR when compared to SHR-S animals. These
findings were associated with renal hemodynamic improvements, decreased cortical NF-ĸB
activity, and improved cortical redox status in SHR-E animals. Overall, our results indicate a
role for decreased RAS activation in the renoprotective effects of ExT in SHR.
The normal parietal tissue of Bowman’s capsule consists of simple squamous epithelium
[153]. Tubular metaplasia of Bowman’s capsule has been well-characterized in SHR and in
aging male Sprague-Dawley rats [153, 173, 174]; however, the exact cause of such metaplasia
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remains uncertain. Metaplasia usually occurs in response to chronic inflammation and allows for
substitution of cells that are better able to survive under circumstances in which a more fragile
cell type might succumb. Although the normal squamous epithelium that lines Bowman's capsule
is robust and more resistant to many insults than is cuboidal epithelium, local changes in
cytokine, growth factor, or extracellular matrix components arising from either increased
glomerular pressure or proteinuria may favor metaplasia to renal tubular epithelium [175]. In
this study, a higher incidence of tubular metaplasia was seen in SHR-S glomeruli than in
glomeruli from any other group, while the incidence of metaplasia in SHR-E glomeruli was
similar to that of WKY-S and WKY-E animals. These differences were not present in WKY or
SHR that were sacrificed at 7 weeks of age, suggesting that the metaplasia seen in SHR-S
glomeruli at study completion may indeed be the result of increased pressure and increased
inflammation, as previously suggested [153]. The absence of significant structural alterations in
SHR-E kidneys was associated with improved renal hemodynamics and decreased inflammation,
while the increased incidence of metaplasia in SHR-S kidneys was associated with a decline in
renal hemodynamics and an increase in inflammation. These results suggest that ExT can
decrease the incidence of pathological changes in SHR kidneys, possibly through a delay in
progression of hypertension and attenuation of inflammation.
We have previously reported an association of PICs and their transcription factor, NF-κB,
with oxidative stress and hemodynamic alterations in the adult SHR kidney [139]. Given the
results from that report and our current results, it is plausible to suggest that the lower NF-κB
activity levels seen in SHR-E animals may be attributable to reductions of PIC and ROS
production and of RAS activation, and thus lead to disruption of the positive feedback cycle
involved with hypertension-induced renal dysfunction.

This study is the first to provide

mechanistic evidence surrounding the effects of chronic exercise on NF-κB activity, oxidative
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stress, hemodynamics, and structure in the SHR kidney. Our results suggest a major role for
exercise training in modulating hypertensive renal injury via decreases in inflammation,
oxidative stress, and RAS activation, and suggest that chronic, moderate-intensity ExT may be a
cost-effective non-pharmacological approach to preventing hypertension and preserving renal
hemodynamics in susceptible patients.
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CHAPTER 4
A BLUEBERRY-ENRICHED DIET ATTENUATES NEPHROPATHY IN A RAT
MODEL OF HYPERTENSION VIA REDUCTION IN OXIDATIVE STRESS
Introduction
Oxidative stress produced by overproduction of reactive oxygen species/reactive nitrogen
species (ROS/RNS) or inefficient antioxidant defenses appears to be involved in the
development and progression of hypertension and hypertension-induced renal injury [176, 177].
The detrimental role of ROS/RNS in hypertension-induced renal injury has fostered an increased
interest in the therapeutic potential of antioxidants; however, the majority of studies thus far have
employed synthetic antioxidants to prevent or attenuate the detrimental effects of ROS both in
vivo and in vitro. Recently, attention has been directed to natural products as sources of
antioxidants [178]. Most plant cells contain antioxidant mechanisms to detoxify free radicals,
which are produced during normal cellular metabolic processes; exogenous stimuli can also
promote free radical production in plants [179]. In particular, small berry fruits have been
demonstrated to have high contents of several antioxidant compounds, including anthocyanins
and other phenolics.

These metabolites function to protect plants against photodynamic

reactions by quenching ROS, and have been suggested to have protective effects against several
human diseases [180, 181].
Blueberries (BB) have among the highest antioxidant capacities of fruits and vegetables
tested to date, and contain polyphenols such as anthocyanins, anthocyanadins, and isoflavones
[182]. BB-enriched diets and BB extracts have been shown to attenuate and even improve agerelated behavioral and neuronal deficits in rodents [183-186]. BB-enriched diets can also
attenuate proinflammatory cytokine production in rat glial cells [187] and protect the rat heart
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from ischemia [188]. Additionally, hypertensive rats on BB-supplemented diets exhibit
significantly lower systolic and mean arterial pressures and renal nitrite content [189].
Therefore, it is plausible to suggest that BB supplementation of the diet may have a tissueprotective effect in various pathologic conditions. In this light, the general objective of the
current study was to assess the chronic effects of a BB-enriched diet on blood pressure (BP) and
renal hemodynamics in a rat model of hypertension-induced renal injury. The hypothesis was
that the BB supplementation of the diet would reduce oxidative stress and thus attenuate renal
damage. As an extension of this hypothesis, rats were also subjected to a short-term (2-day)
exposure of the BB-supplemented diet to determine whether a hormetic effect would be
observed. Hormesis has been proposed as the mechanism mediating the protective effects of
many plant products [190, 191].

Specifically, the hypothesis was that during short-term

exposure, increased ROS/RNS production would be observed which would lead to upregulation
of antioxidant defense mechanisms to enhance long-term protection.
Materials and Methods
Experiment 1: Chronic Feeding Studies
Forty-eight male stroke-prone spontaneously hypertensive rats (SHRSP) and thirty-two
male normotensive Wistar-Kyoto (WKY) rats were used for chronic feeding studies. Rats were
7 weeks old with baseline body weights between 130 and 150 grams. Rats were randomly
divided into four diet groups for each chronic study: WKY cornl (WC), WKY blueberry (WBB),
SHRSP corn (SC), or SHRSP BB (SBB). Animals were fed corn or BB-enriched diets for 6
weeks or 12 weeks.

All animals were subjected to acute renal clearance experiments, as

previously described [176], at the end of the 6-week or 12-week feeding periods. Rats were
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euthanized immediately following renal clearance experiments; kidneys were excised, and cortex
and medulla separated for analyses.
Experiment 2: Short-Term Feeding Studies
For short-term feeding studies to evaluate hormetic effects, 24 additional 7-week-old male
SHRSP were used. Rats (n=12 in each group) were fed corn or BB-enriched diets for 2 days.
Rats were euthanized after which heart, brain, kidney, and liver tissues were collected. In both
2-day and chronic studies, fresh tissues were used for electron paramagnetic resonance (EPR)
spectroscopy studies, and frozen tissues were used for antioxidant studies
Diets
Diets were prepared by Harlan Teklad (Madison, WI) using a reformulated NIH-31 diet
by adding 20 g/kg lyophilized BB or 20 g/kg dried corn. To prepare the 2% BB diet, the berries
were homogenized in water, centrifuged, lyophilized and added to the NIH-31 rodent chow. The
amount of corn in the corn diet was adjusted to compensate for the added volume of BB [192], in
order to make the two diets isocaloric [193]. Food consumption was measured weekly for the
chronic feeding studies by weighing feed before placing it in each cage, and subtracting the
weight of remaining feed at the end of each week. Rats maintained on BB diets for 6 weeks
consumed an average of 371 mg/day (WBB) or 374 mg/day (SBB) of lyophilized blueberries,
roughly equivalent to 4.1g/day or 4.2 g/day, respectively, of fresh blueberries. Rats maintained
on BB diets for 12 weeks consumed an average of 397 mg/day (WBB) or 399 mg/day (SBB) of
lyophilized blueberries, roughly equivalent to 4.4 g/day or 4.5 g/day, respectively, of fresh
blueberries.
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Blood Pressure Measurements
In rats from all chronic feeding groups, tail blood pressures (BP) were measured
noninvasively using a Coda 6 Volume-Pressure Recording System (Kent Scientific, Torrington,
CT), as previously described [194]. Briefly, eight unanesthetized rats from each group were
warmed to an ambient temperature of 30°C by placing them in a holding device mounted on a
thermostatically controlled warming plate. Tail cuffs were placed on animals, and animals were
allowed to acclimate to cuffs for 10 minutes prior to each pressure recording session. Each
session consisted of 30 cycles. BP was measured on five consecutive days each week, and values
were averaged from at least six consecutive cycles. BP was measured at baseline (7 weeks of
age) and then weekly until the end of either chronic study period.
Acute Renal Clearance Experiments
Nine rats from each 6-week feeding group and nine rats from each 12-week feeding
group were subjected to renal clearance experiments at the end of their respective feeding
periods as previously described [176]. Briefly, the right inguinal area was shaved, a small (< 2
cm) incision made, and femoral vessels isolated. The right femoral artery was cannulated with
heparin-primed (100 U/ml) PE-50 polyethylene tubing connected to a pressure transducer
(PowerLab data acquisition system; ADInstruments, Colorado Springs, CO) for continuous
measurement of arterial pressure. The right femoral vein was catheterized with heparin-primed
PE-50 tubing for infusion of solutions at 20 μl/min. An isotonic saline solution containing 6%
albumin was infused via the venous line during surgery for arterial line and bladder catheter
placement. After surgery, the infusion fluid was changed to isotonic saline containing 2% bovine
serum albumin (BSA), 7.5% inulin (Inutest), and 1.5% PAH. The bladder was exposed via a
suprapubic incision and catheterized with a PE-200 tube (with one end flanged) for gravimetric
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urine collection. After a 15- to 20-minute stabilization period, a 30-minute clearance period was
conducted to assess values of renal hemodynamic parameters. An arterial blood sample was
collected at the end of the 30-minute clearance collection period for measurement of plasma
inulin and PAH concentrations. Plasma inulin and PAH concentrations were measured
colorimetrically to determine glomerular filtration rate (GFR) and renal plasma flow (RPF),
respectively.
Electron Paramagnetic Resonance (EPR) Spectroscopy
Total ROS, superoxide (O2•-), and peroxynitrite (OONO-) production rates were
measured in pieces of kidney cortex or medulla (chronic and 2-day feeding studies) and in liver
and cerebral cortex (2-day feeding study) via EPR spectroscopy as previously published [194199] and described in Chapter 2. In this EPR protocol, ‘total ROS’ represents all reactive
oxygen species; however, the major sources trapped by the spin trap used are superoxide,
hydrogen peroxide, and hydroxyl radical, with other species as minimal contributors. Briefly,
tissue pieces were incubated at 37oC with 6.6 μl of CMH (200 μM) for 30 minutes for ROS
measurement; 1.5 μl of PEG-SOD (50 U/μl) for 30 minutes, then CMH for an additional 30
minutes for superoxide measurement; or 30 μl of CPH (500 μM) for 30 minutes for peroxynitrite
measurement.

Aliquots of incubated probe media were then taken in 50 μl disposable glass

capillary tubes (Noxygen Science Transfer and Diagnostics, Elzach, Germany) for determination
of total ROS, superoxide, or peroxynitrite production.
Measurement of Antioxidant Status
Catalase activity and total glutathione (GSH) levels were measured in kidney cortex and
medulla (chronic and 2-day feeding studies) and also in liver and left ventricle (2-day feeding
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study) using commercially available kits (Cayman Chemical, Ann Arbor, MI) according to
manufacturer’s instructions, as previously described [200].
Statistical Analyses
A two-way ANOVA (strain x diet) was used to analyze blood pressure, food
consumption, body weight, physiological, biochemical, and EPR data at each time-point. Where
significant main effects or interactions were found, individual planned comparisons were made
using Student’s t-tests for all other chronic feeding study data specifically to compare WC and
WBB animals; WC and SC animals; and SC and SBB animals. T-tests were also used to
compare results from SHR C and SHR BB groups for the 2-day feeding study. In all cases,
p≤0.05 was accepted as the level of statistical significance.
Results
Chronic Feeding Studies
Consistent with past studies using similar dietary formulations [183, 188, 189, 201],
weekly food consumption and body weight gain did not differ among any of the diet groups in
the chronic feeding studies. Mean starting body weights in the WKY and SHR animals at
baseline before assignment to groups were 138 ± 3 g and 142 ± 2 g, respectively; at the end of
the 6 week study, the mean body weights were as follows: WC = 252 ± 9 g; WBB = 246 ± 3 g;
SC = 250 ± 3 g; and SBB = 252 ± 3g. At the end of the 12 week study, mean body weights were
as follows: WC = 346 ± 4 g; WBB = 342 ± 5 g; SC = 334 ± 6 g; and SBB = 333 ± 8 g.
Figure 4.1 presents the BP trends for each group of rats in both the 6-week and 12-week
studies. Compared to SC rats, the mean arterial and systolic pressures of the SBB rats were
significantly lower by the second week of the 6-week and 12-week studies, and remained
significantly lower for the remainders of both chronic studies.
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Table 4.1 presents the

renoprotective effects of BB diet in SHRSP rats fed for 6 weeks or 12 weeks. Glomerular
filtration rate and renal blood flow were higher, and renal vascular resistance was lower, in 6week and 12-week SBB rats when compared to SC rats. There were no significant differences in
renal hemodynamic or BP measures between WC or WBB animals. The decreases in total ROS,
superoxide, and peroxynitrite seen with chronic BB feeding for 6 or 12 weeks appear in Table
4.2. For both 6- and 12-week studies, SBB rats exhibited significantly lower free radical
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Figure 4.1. Blueberry-enriched diet delays the progression of hypertension. Mean arterial and
systolic blood pressures were assessed in rats fed a corn diet or a blueberry-enriched diet for 6
weeks (A) or 12 weeks (B). * p<0.05 vs. SC; † p<0.05 vs. SBB.
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Table 4.1. Renal hemodynamic indices in corn- or blueberry-fed rats after 6 weeks or 12 weeks
of feeding.
WC
6
WEEKS
12
WEEKS
*

GFR
RBF
RVR
GFR
RBF
RVR

WBB
*

0.95 ± 0.05
7.98 ± 0.25*
13.33 ± 0.70*
0.90 ± 0.06*
7.03 ± 0.25*
15.98 ± 1.14*

0.92 ± 0.05
8.42 ± 0.32
14.28 ± 1.24
1.11 ± 0.09
8.42 ± 0.75
14.05 ± 1.41

SC

SBB
†

0.59 ± 0.04
5.96 ± 0.35†
28.04 ± 1.39†
0.53 ± 0.04†
3.62 ± 0.22†
36.71 ± 2.10†

0.97 ± 0.07*
7.71 ± 0.17*
13.34 ± 0.63*
1.02 ± 0.07*
6.80 ± 0.59*
15.49 ± 1.22*

p<0.05 vs. SC; † p<0.05 vs. SBB.

Table 4.2. Total ROS, superoxide, and peroxynitrite production rates as measured by EPR in
tissues of corn- or blueberry-fed rats after 6 or 12 weeks of feeding.
WC

WBB

SC

SBB

KIDNEY CORTEX
Total ROS
6 weeks
12 weeks
Superoxide
6 weeks
12 weeks
Peroxynitrite
6 weeks
12 weeks

*

Total ROS
6 weeks
12 weeks
Superoxide
6 weeks
12 weeks
Peroxynitrite
6 weeks
12 weeks

0.067 ± 0.012*
0.115 ± 0.013*

0.099 ± 0.005$
0.112 ± 0.009$

0.199 ± 0.027
†
0.429 ± 0.038

†

0.069 ± 0.011*
0.195 ± 0.026*

0.040 ± 0.014*
0.067 ± 0.018*

0.028 ± 0.006
0.063 ± 0.013

0.136 ± 0.026
†
0.165 ± 0.013

†

0.030 ± 0.007*
0.063 ± 0.006*

†
0.022 ± 0.003$
0.053 ± 0.011
†
0.028 ± 0.004
0.111 ± 0.021
KIDNEY MEDULLA

0.011 ± 0.003*
0.028 ± 0.020*

0.017 ± 0.002*
0.020 ± 0.006*

0.077 ± 0.011*
0.157 ± 0.014*

0.087 ± 0.007$
0.151 ± 0.018

0.188 ± 0.025
†
0.314 ± 0.017

†

0.118 ± 0.010*
0.170 ± 0.017*

0.056 ± 0.011*
0.079 ± 0.012*

0.051 ± 0.013
0.075 ± 0.008

0.122 ± 0.009
†
0.164 ± 0.017

†

0.048 ± 0.011*
0.089 ± 0.019*

0.027 ± 0.006*
0.052 ± 0.017*

0.021 ± 0.005
0.065 ± 0.005$

0.050 ± 0.005
†
0.128 ± 0.009

†

0.025 ± 0.005*
0.031 ± 0.007*

p<0.05 vs. SC; † p<0.05 vs. SBB.
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The increases in cortical and medullary catalase and glutathione activities noted with
chronic BB-enriched diet feedings appear in Figures 4.2 and 4.3, respectively. For both chronic
feeding studies, SBB rats exhibited significantly higher catalase and glutathione activities than
SC rats. There were no differences in antioxidant activities between WC and WBB rats at the
conclusion of the 6- or 12-week studies.

Figure 4.2. Blueberry-enriched diet improves glutathione activity in hypertensive rats.
Glutathione activities were assessed in renal cortical and medullary tissues of rats fed a corn diet
or a blueberry-enriched diet for 6 weeks (A) or 12 weeks (B). *p<0.05; ** p< 0.01; *** p<0.001.
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Figure 4.3. Blueberry-enriched diet improves catalase activity in hypertensive rats. Catalase
activities were assessed in renal cortical and medullary tissues of rats fed a corn diet or a
blueberry-enriched diet for 6 weeks (A) or 12 weeks (B). *p<0.05; ** p< 0.01; *** p<0.001.

Short-Term Feeding Studies
No significant differences were found in body weights between corn- or BB-diet fed
animals in the 2-day feeding study. As noted in Table 4.3, significant increases in production
rates of total ROS, superoxide, and peroxynitrite were observed in cerebral cortex, liver, kidney
cortex, and kidney medulla of rats fed a BB diet for 2 days compared to those on corn diet.
Table 4.4 depicts the catalase and glutathione activities recorded in heart, liver, and kidney
tissues of 2-day BB-fed SHRSP when compared to corn diet-fed SHRSP. In the left ventricle
and kidney cortex of SHRSP fed BB-diet for 2 days, catalase activities were increased when
compared to those of SHRSP fed a corn diet for 2 days. However, total GSH levels were lower
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in the left ventricle of 2 day BB-fed rats when compared to 2-day corn diet-fed rats, with no
significant changes in GSH levels noted in other tissues assayed.
Table 4.3. Total ROS, superoxide, and peroxynitrite production rates as measured by EPR in
tissues of corn- or blueberry-fed rats after 2 days of feeding.
CEREBRAL CORTEX
Total ROS
Superoxide
Peroxynitrite
LIVER
Total ROS
Superoxide
Peroxynitrite
KIDNEY CORTEX
Total ROS
Superoxide
Peroxynitrite
KIDNEY MEDULLA
Total ROS
Superoxide
Peroxynitrite

Corn (n= 7)

Blueberry (n= 7)

P

0.126 ± 0.008
0.024 ± 0.003
0.005 ± 0.001

0.156 ± 0.015
0.039 ± 0.005
0.022 ± 0.003

0.0417
0.0087
0.0004

0.371 ± 0.026
0.150 ± 0.007
0.014 ± 0.002

0.530 ± 0.057
0.246 ± 0.023
0.042 ± 0.007

0.0129
0.0046
0.0069

0.140 ± 0.013
0.041 ± 0.005
0.015 ± 0.002

0.210 ± 0.022
0.063 ± 0.004
0.034 ± 0.004

0.0289
0.0275
0.0044

0.146 ± 0.011
0.060 ± 0.011
0.035 ± 0.006

0.189 ± 0.019
0.106 ± 0.025
0.075 ± 0.011

0.0136
0.0258
0.0158

Table 4.4. Catalase and total glutathione (GSH) levels as measured by colorimetric assays in
tissues of corn- or blueberry-fed rats after 2 days of feeding.
LEFT VENTRICLE
Catalase
Total GSH
LIVER
Catalase
Total GSH
KIDNEY CORTEX
Catalase
Total GSH
KIDNEY MEDULLA
Catalase
Total GSH

Corn (n= 8-10)

Blueberry (n= 8-10)

P

0.293 ± 0.019
2.68 ± 0.243

0.373 ± 0.022
1.89 ± 0.213

0.0285
0.0495

0.287 ± 0.011
1.91 ± 0.159

0.276 ± 0.016
1.85 ± 0.065

n.s.
n.s.

0.246 ± 0.012
2.11 ± 0.187

0.306 ± 0.020
2.23 ± 0.091

0.0331
n.s.

0.325 ± 0.010
2.23 ± 0.207

0.310 ± 0.028
2.17 ± 0.065

n.s.
n.s.
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Discussion
Primary (essential) hypertension remains a major cause of morbidity and mortality in
Western society, and continues to be a leading cause of heart and kidney diseases [202]. The
cause(s) of primary hypertension remain elusive; however, oxidative stress and proinflammatory
cytokine production are known contributors [203, 204].

Nephropathy resulting from

hypertension is the second leading cause of end-stage renal disease in the United States [202];
therefore, the most effective way to avoid the development of hypertensive nephropathy is to
prevent hypertension or to delay its progression. In many cases, hypertension can be attenuated
with pharmacological treatments including, but not limited to: diuretics, beta receptor
antagonists, angiotensin converting enzyme antagonists, and angiotensin II receptor antagonists;
however, these commonly used anti-hypertensives can also have undesirable side effects.
Therefore, it is valuable to consider natural products, such as foods, as potentially therapeutic
sources of antioxidants for a variety of conditions.
Thus far, a variety of pharmacotherapies have proven successful in decreasing renal
damage in hypertensive animals; however, the possible benefits of dietary interventions have
only recently come into focus. BB-enriched diets have been shown to decrease renal nitrite
content, protect the myocardium from ischemia, and correct neurological deficits in rats [183,
185-189]. In the present study, we show for the first time that regular dietary supplementation
with blueberries in SHRSP rats preserves renal hemodynamics and prevents oxidative stress in
the kidney. We also demonstrate that BB may act via a hormetic mechanism in preventing
oxidative stress in the SHRSP rat.
After 6 weeks and 12 weeks of BB feeding, GFR and RBF measures were higher,
estimated RVR was lower, renal free radical production was attenuated, and renal antioxidant
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levels were preserved in BB-fed SHRSP when compared to those of SHRSP maintained on a
corn diet. The results of our chronic feeding experiments also demonstrate that total ROS,
superoxide, and peroxynitrite production rates were significantly lower and antioxidant activities
were significantly higher in BB-fed SHRSP than in corn-fed SHRSP. These results clearly
demonstrate a protective antioxidant effect of BB feeding. The imbalance between superoxide
production and NO production in the kidney is a primary contributor to renal oxidative stress and
salt-sensitive hypertension [205, 206]. Oxidative stress is further enhanced in the kidneys of
SHRSP that are salt-loaded (as were the SHRSP in this study) [206, 207]. We demonstrate here
that the BB diet protected against oxidative renal damage by attenuating free radical production
and preserving antioxidant status, and thereby improving BP and renal hemodynamics.
A possible mechanism for this renoprotection may be the scavenging of superoxide in
kidney tissues, which has been shown to lower BP in various models of hypertension [206, 208].
BB are known scavengers of ROS/RNS, including superoxide, in vitro [209]. In further support
of a renal superoxide scavenging mechanism, we found that the cortical and medullary
production rates of peroxynitrite in BB-fed rats from both 6- and 12-week time-points were
significantly lower compared to rats fed the corn diet. Nitric oxide reacts readily with superoxide
to form the highly cytotoxic peroxynitrite radical; therefore, one explanation for the decline in
peroxynitrite production in BB-fed animals is an increase in nitric oxide, which can foster the
removal of superoxide. Further study is needed to determine conclusively whether this effect is
responsible for the renoprotection afforded by chronic BB feeding.
These chronic feeding studies were not intended to analyze specific signaling pathways
responsible for preservation of renal hemodynamics and/or reduction of oxidative stress in the
kidneys of hypertensive animals on a BB-enriched diet, but rather as a proof of concept. One
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assertion that can be made on the basis of these findings is that alterations in signaling were
likely associated with decreases in ROS/RNS production and improvements in ROS/RNS
scavenging, which likely affected inflammatory status.

Although we did not examine

inflammation in these studies per se, we can infer, based on our previous research, that this effect
was mediated in part through the inflammatory nuclear factor kappa B (NF-ĸB) pathway, which
can both induce and respond to oxidative stress [193]. Inferences can also be made on the basis
of previous studies.

BB extract can significantly inhibit the lipopolysacharide-induced

inflammatory response in brain microglia by downregulating inducible nitric oxide synthase;
therefore, BB extract may indeed inhibit an early step of the inflammatory stress pathway
transcribed by NF-ĸB [187]. In the same model of mouse microglial cells, BB extract also
inhibited the expression of cyclooxygenase-2, which is known to be associated with the NF-ĸBregulated proinflammatory cytokines, interleukin-1β and tumor necrosis factor-α [187].
Extrapolating from these findings, it is plausible to suggest that some of the same
oxidative/inflammatory mechanisms may be at work in the hyptertensive kidney.
Our results from the 2-day feeding study indicate that a hormetic effect of BB may
indeed exist in the prevention of hypertension-induced renal hemodynamic alterations. The
‘xenohormesis’ hypothesis proposes that animal species have evolved the ability to use chemical
cues from plant species to mount a preemptive defense response that increases its chances of
survival [191, 210]. Polyphenols, among other phytochemicals, are thought to exert many of
their beneficial effects via hormetic mechanisms [210]. In contrast to the clear evidence of
reduced ROS/RNS production in the long-term studies, results from the 2-day feeding study
indicated significant increases in total ROS, superoxide, and peroxynitrite production in kidney,
brain, and liver tissues of BB-fed rats when compared to corn-fed rats. As a response to this
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situation, increased catalase activities were found with 2-day BB feeding, but only in kidney
cortex and left ventricular tissues. Overall, the EPR and antioxidant assay results suggest that, in
the case of BB feeding, an initial oxidative stimulus is produced, which is presumably required
for the antioxidant defense to be activated, thereby supporting the assertion that a hormetic effect
is involved in the protection afforded by BB in vivo. Since we evaluated hormetic responses
only at the 2-day time-point of BB exposure, further analysis is required to document in detail
the kinetics of ROS production and antioxidant responses.
In summary, our experiments examining rats chronically maintained on a BB-enriched
diet for 6 or 12 weeks found preservation of renal hemodynamics and decreased blood pressure.
Further, the BB diet decreased ROS/RNS production and preserved antioxidant status in the
kidney cortex and medulla of chronically fed hypertensive rats. The beneficial effects of the BB
diet may be due to a hormetic effect, as evidenced by our results from the 2-day feeding
experiment, where ROS/RNS production was increased in all tissues of BB-fed animals, while
response of the antioxidant system was in a state of flux, with some systems elevated at that
time-point and others unresponsive. This is the first demonstration, to our knowledge, of the
effectiveness of a readily available natural product in an acceptable, consumable quantity to
significantly attenuate hypertension-induced renal functional alterations.
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CHAPTER 5
A BLUEBERRY-ENRICHED DIET DELAYS RENAL FAILURE IN THE STROKEPRONE SPONTANEOUSLY HYPERTENSIVE RAT
Introduction
Nephropathy is a leading cause of morbidity and mortality in hypertensive patients [211].
Many preferred pharmacological treatments for hypertension are renoprotective; however, the
clinical courses of hypertension and its associated target organ damage remain progressive.
Therefore, a continuous need for new therapeutic approaches exists.

Oxidative stress and

inflammation are common features of hypertensive nephropathy and also contribute to its
progression [212-215]. Oxidative stress in hypertension is caused by a combination of increased
reactive oxygen species (ROS) production and impaired antioxidant defenses [215-220].
Increased ROS production can modify various structural and functional molecules and activate
redox-sensitive transcription factors, thereby leading to tissue injury and promoting
inflammation, fibrosis, and further ROS production [221, 222].
The beneficial effects of antioxidant-rich diets in attenuating hypertension and improving
endothelial function are well-established in animals and humans [223-227].

The Dietary

Approaches to Stop Hypertension study, which implemented a fruit- and vegetable-rich diet in
hypertensive patients, resulted in significant blood pressure reductions in those patients [228].
Further, epidemiological evidence indicates that dietary antioxidants may delay the onset of
hypertension in some individuals [229, 230]. Previous studies have shown that polyphenol-rich
fruits and vegetables are beneficial in both delaying and treating hypertension [231, 232]. The
protective effects observed in these studies may be due to the antioxidant and anti-inflammatory
properties attributed to polyphenolic compounds. Since inflammation and oxidative stress are
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associated with hypertension-related renal injury, it is plausible to suggest that consumption of
foods high in antioxidants and anti-inflammatory agents may delay or prevent its development.
The oxygen radical absorbance capacity (ORAC) assay is a widely accepted method for
measuring the total antioxidant capacities of fruits and vegetables [233, 234]. The ORAC value
for blueberries is one of the highest among all fruits and vegetables [235, 236]; consequently,
blueberries have been shown to protect against inflammation [237, 238], oxidative stress [237,
239, 240], and chronic diseases [241].

Recent research has highlighted the promise of

blueberries in lowering blood pressure and tissue nitrites in spontaneously hypertensive strokeprone (SHRSP) rats [227], in addition to protecting the heart from ischemic damage [242] and
improving cognition and other neurological parameters [239, 243]. However, the direct effects
of a blueberry-enriched diet on renal hemodynamics and renal oxidative stress have not yet been
examined; this was the focus of the present study. Here, we hypothesized that supplementing a
stroke-permissive rodent diet with 2% blueberry (BB) extract for 10 weeks would preserve renal
hemodynamics and beneficially alter redox status in the SHRSP kidney.
Materials and Methods
All experimental procedures were in compliance with all applicable principles set forth in
the National Institutes of Health Guide for the Care and Use of Laboratory Animals (Publication
No.. 85-23, revised 1996). This study was approved by the Institutional Animal Care and Use
Committee of the Louisiana State University School of Veterinary Medicine.
Chemicals and Drugs
Inulin (polyfructosan-S; Inutest) was obtained from Fresenius-Kabi (Graz, Austria) and
para-aminohippurate (PAH) was obtained from Merck, Sharp & Dohme (West Point, PA). The
spin probes 1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine (CMH), 1-hydroxy95

3-carboxypyrrolidine (CPH), and 1-hydroxy-4-phosphono-oxy-2, 2, 6, 6-tetramethylpiperidine
(PPH); the metal chelators defferoxamine (DF) and diethyldithiocarbamate (DETC); and KrebsHEPES buffer (KHB) were obtained from Noxygen Science Transfer and Diagnostics (Elzach,
Germany).

Polyethylene

glycol-conjugated

superoxide

dismutase

(PEG-SOD)

thiobutabarbital (Inactin) were obtained from Sigma-Aldrich (St. Louis, MO).

and

All other

chemicals and reagents used were of analytical grade and were purchased from Sigma-Aldrich
unless otherwise specified.
Animals
Eighteen male spontaneously hypertensive stroke prone rats (SHRSP) and six
normotensive Wistar-Kyoto (WKY) control rats were used in this study. Animals were 21 days
old at the start of the experiment. All animals were provided food and water ad libitum, and
maintained in a temperature (23 ± 2°C)- and light (12 hour light/dark cycle)-controlled
environment. Prior to the start of the experiment, rats were randomly assigned to one of four diet
groups.

Rats were maintained on diets for ten consecutive weeks: WKY Japanese stroke

permissive (JSP) diet, SHRSP regular diet, SHRSP JSP diet, or SHRSP JSP BB-supplemented
(JSP BB) diet. The JSP diet is low in protein and potassium and high in sodium, and has been
demonstrated to accelerate organ pathology in the SHRSP rat [244-246]. Rats were fed their
respective diets for 10 weeks, from date of weaning (age 3 weeks) until the age of 14 weeks. All
animals were provided 1% NaCl in tap water for the duration of the study; when combined with
JSP diet, this has previously been demonstrated to induce early renal damage in the SHRSP
model [244-247].

96

Diets
Blueberry preparations were a generous gift from Drs. Barbara Shukitt-Hale and James
A. Joseph (Tufts University, Boston, MA). Blueberries were prepared as previously described
[248, 249]. Briefly, blueberries were homogenized and centrifuged, and the supernatant was
then frozen, crushed, and lyophilized. Freeze-dried blueberry preparations were then shipped to
Harlan Teklad (Madison, WI), where they were combined with the JSP control diet at 20 grams
per kilogram diet (2% w/w). Macronutrient compositions of both diets appear in Table 5.1.
Table 5.1. Macronutrient contents of control and blueberry-enriched diets.
% by weight
Protein
Carbohydrate
Fat
Kilocalories/gram
% kcal from:
Protein
Carbohydrate
Fat

Control Diet
16.4
48.5
4.0
3.0
Control Diet
22
66
12

BB-Enriched Diet
16.0
53.5
3.5
3.1
BB-Enriched Diet
21
69
10

Animal Monitoring and Surgical Procedures
After ten weeks on the control, JSP, or JSP BB diets, each rat was anesthetized with
Inactin (thiobutabarbital; 100 mg/kg), and then underwent surgery for catheterization of the
femoral artery, femoral vein, and bladder; acute renal clearance experiments were then
performed as previously described [222]. Arterial pressures were obtained for each animal
during surgery, via a fluid-filled pressure transducer.

After completion of renal clearance

studies, rats were euthanized by Inactin overdose. The chest was then cut to expose the heart,
and blood was removed via cardiac puncture. Kidney tissues and plasma were collected for later
analyses.
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Glomerular Injury Scoring and Histopathological Evaluation
Trichrome-stained kidney sections (3 μm) from rats were examined by a veterinary
pathologist who was blinded to the experimental conditions. One hundred glomeruli from each
section were scored. A semi-quantitative glomerular lesion scoring method was used, which was
based upon previously published methods for glomerulosclerosis scoring [250] and expanded to
include the following criteria: tubular epithelial metaplasia of Bowman’s capsule,
glomerulosclerosis, mesangial proliferation, and glomerular capillary basement membrane
thickening. A detailed explanation of this scoring method appears in Chapter 3.
NF-ĸB p65 DNA Binding Activity Assay
The binding of NF-ĸB p65 to its DNA consensus binding site was measured in renal
cortical nuclear extracts with a TransAM NF-ĸB p65 ELISA Kit (Active Motif; Carlsbad, CA),
according to manufacturer’s instructions, as previously described in Chapter 3.
Western Blotting
Protein expression in renal cortical nuclear and cytoplasmic extracts was analyzed by
western blot as previously described [222, 251], using anti-p65, anti-SIRT1, anti-JNK, antiphospho-JNK, anti-histone H1 and anti-GAPDH antibodies.

Densitometry analyses were

performed with Image J software. Three blots each were performed for the SIRT1 antibody;
each membrane was then reblotted with anti-histone H1 antibody (nuclear loading control).
Three blots each were performed for JNK and phospho-JNK antibodies; each membrane was
then reblotted with anti-GAPDH antibody (cytoplasmic loading control).
Cortical Tissue EPR Measurements
Cortical total ROS, superoxide, and peroxynitrite production rates were measured using
EPR spectroscopy as previously described [222, 252].
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In this EPR protocol, ‘total ROS’

represents all reactive oxygen species; however, the major sources trapped by the spin trap used
are superoxide, hydrogen peroxide, and hydroxyl radical, with other species as minimal
contributors.
Measurement of Nitrate/Nitrite Levels
Nitrate/nitrite levels (indirect indicator of NO activity) were measured in kidney cortex
using a commercially available kit, according to manufacturer’s instructions (Cayman Chemical,
Ann Arbor, MI), as previously described [252].
Measurement of Catalase and Glutathione Levels
Cortical antioxidant status was assessed by measurement of catalase and total glutathione
levels in kidney cortex using commercially available kits, according to manufacturer’s
instructions (Cayman Chemical, Ann Arbor, MI), as previously described [222, 253].
Statistical Analyses
All data are presented as means ± SEMs. A two-way ANOVA (strain x diet) was used to
analyze blood pressure, food consumption, and body weight data. Where significant main
effects or interactions were found, individual planned comparisons were made using Student’s ttests for all other parameters measured, specifically to compare WKY and SHRSP animals;
SHRSP and JSP animals; and JSP and JSP BB animals. In all cases, p≤0.05 was accepted as the
level of statistical significance.
Results
In a pilot study with eight SHRSP rats fed the JSP diet, only three rats survived until 10
weeks of age (Figure 5.1). In the WKY, SHR, and JSP BB groups, all animals survived until
study end. These results indicate that BB supplementation prolongs survival in the SHRSP
model of hypertensive nephropathy. At study end, JSP animals had significantly lower body
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weights than SHRSP and JSPBB animals. No differences in body weights were noted between
WKY and SHRSP animals (Table 5.2).
Mean arterial pressures and systolic blood pressures were significantly higher in the JSP
group than in the JSP BB or SHRSP groups at study end (Table 5.2). Interestingly, WKY
animals fed the JSP diet did not exhibit elevations in blood pressure. Significantly higher GFR
and RBF values and significantly lower RVR and urine albumin values were seen in JSP BB
animals when compared to the JSP group; these results suggest that BB supplementation
preserves renal hemodynamics in the SHRSP rat fed a stroke-permissive diet. Further, urinary
albumin levels were significantly higher in the JSP group than in the JSP BB or SHRSP groups
at study end; these results further demonstrate the preservation of renal function in BB-fed rats.

Figure 5.1. A survival curve was constructed to determine the effects of a blueberry-enriched
diet on survival in stroke-prone SHR. JSP animals began to die at 5 weeks of age; only 3
animals remained at the conclusion of the study. All WKY and all JSP BB animals survived the
duration of the 10 week study.
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Table 5.2. Renal hemodynamic parameters obtained from all animals at study conclusion.
BW (g)
MAP (mmHg)
SBP (mmHg)
GFR (ml/min/g KW)
RBF (ml/min/g KW)
RVR(mmHg/ml/min/g KW)
Urine Albumin (mg/dl)
$

WKY
322±8.95
92.7±2.61†
120.8±3.71†
0.99±0.10†
6.94±0.62†
13.64±1.16†
41.8±3.79†

SHRSP
309±5.81*
131.1±2.21$
158.6±5.59$
0.65±0.04*$
5.81±0.46*$
24.09±3.53*$
53.3±1.65$

JSP
281±7.14†#
153.9±2.63#
182.6±7.69#
0.42±0.04†#
3.07±0.21†#
43.74±1.68†#
65.7±2.67†#

p<0.05 vs. WKY; † p<0.05 vs. SHRSP; * p<0.05 vs. JSP; # p<0.05 vs. JSP BB.

JSP BB
301±1.65*
126.2±7.42*
143.9±6.84*
0.80±0.04*
5.69±0.25*
29.27±2.85*
49.9±2.21*

Rats from the JSP group had significantly higher glomerular lesion scores than rats from
SHRSP and JSP BB groups at the completion of the study (Figure 5.2A). There were similar
histopathologic changes in all hypertensive rats; however, the prevalence and severity of changes
differed between groups (Figures 5.2B-E).

In the end-stage kidneys seen in the JSP rats,

profound arterial sclerosis and frequent arterial thrombosis were present. JSP BB rats also had
arteriosclerosis but had less frequent thromboses. As expected, given the circulatory
compromise, the degree of tubular degeneration and dilation in the JSP rats was much more
severe than in JSP BB rats. Although changes in glomeruli were similar in JSP and JSP BB
groups, greater protein accumulation in Bowman’s space and in tubules suggests that the JSP rats
had more severe glomerular leakage/damage; these findings are further supported by the
significantly higher urinary albumin levels in the JSP animals and the decrease in urinary
albumin levels seen with BB feeding.

101

Figure 5.2. A) Glomerular scores for rats in all experimental groups. B) WKY rat kidneys had
mild periarterial fibrosis and minimal smooth muscle hyperplasia (long arrow). Mild interstitial
fibrosis was also present (in the right upper corner of the image) and there was rare tubular
degeneration (*). C) SHRSP kidneys exhibited moderate periarterial fibrosis (long arrow) and
mild smooth muscle hyperplasia. Occasional senescent glomeruli (#) were also present. D) JSP
rat kidneys exhibited medium-sized arteries with hypertrophied tunica media and moderate
periarterial fibrosis, which were often thrombosed with remodeling and recanalization (long
arrow). The JSP kidneys also had more frequent tubular degeneration (*) and areas of tubular
regeneration (short arrow – tubules lined by increased numbers of plump epithelial cells). They
also had more frequent tubular ectasia (**) with eosinophilic to lightly basophilic proteinaceous
casts. Occasional hemoglobin casts within degenerate tubules were also seen in this group (>).
E) In JSP BB rat kidneys, medium-sized arteries typically had hypertrophied tunica media with
moderate periarterial fibrosis (black arrow), occasional mildly dilated tubules lined by flattened
tubular epithelium (* tubular degeneration), occasional glomeruli with mild glomerular
sclerosis/fibrosis (<), and occasional dilated tubules with flattened epithelium and lightly
eosinophilic proteinaceous casts (**). Scale bars = 100 μm.
Protein expression levels of collagen III and TGF-β were assessed in animals from all
experimental groups. There were no significant differences in collagen III or TGF-β levels
between WKY and SHRSP rats; however, levels of both proteins were significantly higher in
JSP rats when compared to SHRSP rats. JSP BB rats had significantly lower expression of both
proteins, indicating a decrease in profibrotic molecules in the kidneys of these animals.
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Figure 5.3. A) Representative western blots for collagen III and TGF-β in animals from all
experimental groups. B) Densitometric analyses of western blots for collagen III and TGF-β. *
p<0.05; ** p<0.01; ***p<0.001.

We measured total ROS, superoxide, and peroxynitrite production rates using EPR
spectroscopy in cortical tissues from rats in all experimental groups. Production rates of all
species measured were significantly lower in tissues of WKY rats when compared to SHRSP
rats, in SHRSP rats when compared to JSP rats, and in JSP BB rats when compared to JSP rats
(Table 5.3).
Catalase and total glutathione levels were measured in renal cortical tissues from animals
from all experimental groups. We found significantly lower catalase and glutathione levels in
SHRSP animals when compared to WKY animals, and in JSP animals when compared to
SHRSP or JSP BB animals (Table 5.3)
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Table 5.3. Free radical production rates and antioxidant activities obtained from cortical tissues
at study conclusion.
Total ROS
Superoxide
Peroxynitrite
Catalase
Total GSH
$

WKY
0.094±0.019†
0.032±0.008†
0.026±0.005†
0.99±0.09†
6.98±0.83†

SHRSP
0.174±0.021*$
0.066±0.006*$
0.050±0.002*$
0.57±0.05$
4.56±0.54*$

JSP
0.414±0.085†#
0.119±0.015†#
0.089±0.013†#
0.54±0.04#
2.71±0.35†#

p<0.05 vs. WKY; † p<0.05 vs. SHRSP; * p<0.05 vs. JSP; # p<0.05 vs. JSP BB.

JSP BB
0.069±0.007*
0.023±0.009*
0.025±0.005*
0.79±0.08*
6.47±0.61*

NF-ĸB p65 DNA binding activity was measured in cortical nuclear extracts from animals
from all experimental groups. There was no difference in p65 DNA binding activity levels
between WKY and SHRSP groups. A significant increase was seen in p65 DNA binding activity
in the JSP group when compared to the SHRSP group; this increase was prevented with BB
feeding (Figure 5.4).

Figure 5.4. NF-ĸB p65 DNA binding activity measurements for cortical tissues from each
experimental group. The p65 DNA binding activity of JSP tissues was greater than that of
SHRSP, and BB feeding attenuated this increase. ***p<0.001.
Interestingly, total JNK expression only differed between SHRSP and JSP rats, while
increased pJNK expression was seen in SHRSP rats when compared to WKY rats. A further
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increase in pJNK expression was seen in JSP rats when compared to SHRSP rats; this increase
was alleviated in the JSP BB rats. A significant decrease in SIRT1 expression was observed in
JSP rats when compared to SHRSP rats, while this decrease was attenuated in JSP BB rats.

Figure 5.5. A) Representative western blots showing protein expression for total JNK,
phosphorylated JNK, and SIRT1. GAPDH was used as the cytoplasmic loading control and
histone H1 was used as the nuclear loading control. B) Densitometric analyses of total JNK,
phospho JNK, and SIRT1 expression levels. * p<0.05; ** p<0.01; ***p<0.001.

Discussion
This study is the first to examine the beneficial effects of BB supplementation on renal
structure and function in a model of severe hypertensive nephropathy. We hypothesized that
supplementation of a stroke-permissive diet with 2% lyophilized blueberry would result in
preservation of renal function and decreased oxidative stress in the salt-loaded SHRSP. When
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fed a BB-enriched stroke-permissive diet, salt-loaded SHRSP demonstrated a preservation of
renal hemodynamics, decreased urinary albumin loss, and a significant decrease in ROS/RNS
production. Preservation of these parameters was accompanied by decreases in blood pressure
and inflammation.
Renal damage is a major contributor to the development of hypertension in rats [254257]. An imbalance between renal superoxide and nitric oxide production is a primary
determinant of renal oxidative stress, leading to salt-sensitive hypertension [255, 258]. Further,
oxidative stress is enhanced in the kidneys of SHRSP that are salt-loaded [255, 256], and
becomes even more severe with the addition of a stroke-permissive diet, as was done in this
study.

In JSP rats, albuminuria was evident, along with significant declines in renal

hemodynamic parameters and increased severity of renal lesions, indicating severe renal damage.
Blueberry supplementation led to decreased urine albumin, preservation of renal hemodynamics,
and decreased severity of renal pathology, suggesting that BB feeding can mitigate renal
damage.
One possible mechanism for the protection seen with BB feeding may be scavenging of
renal superoxide, which can significantly reduce BP in various animal models of salt-sensitive
hypertension [240, 255, 256, 259]. Blueberries are potent scavengers of superoxide and other
ROS in vitro [260, 261] and have been shown to reduce renal nitrites. Other antioxidants lower
BP in SHR by diminishing renal damage and proteinuria [259, 262, 263]. Studies have also
demonstrated that blueberry extract can inhibit NF-ĸB translocation and subsequently suppress
the promoter activities of genes involved in inflammation in microglial cells, including iNOS and
COX2 [264]. BB-enriched diets have also been shown to down-regulate the signaling cascades
of several MAP kinases known to respond to oxidative stress, including that of JNK [265, 266].
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The reduction in renal ROS/RNS production found in the JSP BB rats, along with improved
activity of catalase and GSH, suggests an overall improvement in redox status in these animals,
and implies an antioxidant effect of BB in the kidney. Similar effects have been found with the
use of pharmacological antioxidants in hypertensive rats [267]. Also in agreement with those
studies, we found a decrease in blood pressure elevation and improved renal hemodynamics in
BB-fed rats, which can be attributed to decreased oxidative stress. Further, we found decreases
in phosphorylated JNK, a redox-sensitive signaling molecule, and in activation of the redoxsensitive transcription factor, NF-ĸB.
We and others have demonstrated that increased ROS/RNS production can increase renal
NF-κB activation in the hypertensive condition, thereby promoting the inflammatory response
[213, 222, 268]. In the present study, we show an increase in NF-κB activation in kidney tissues
of SHRSP rats compared to WKY rats, with a further increase in NF-κB activation in JSP
kidneys compared to SHRSP kidneys. We also demonstrate that NF-κB activation is attenuated
in kidneys of JSP rats fed a BB-enriched diet. Further, the decrease seen in NF-κB activation in
the JSP BB animals was associated with decreased expression of phosphorylated JNK, a MAP
kinase known to be up regulated in the kidneys of hypertensive rats [269, 270].

Historically,

JNK has been shown to act through the transcription factor, activator protein-1 (AP-1).
Recently, however, Cuhlmann et al reported a JNK-dependent activation of NF-κB in mouse
arteries in response to disturbed blood flow, which led to arterial inflammation [271].

It is

possible that this mechanism may be at work in the kidney, given our results demonstrating
increased pJNK expression in association with increased NF-ĸB activation.

Also, nuclear

expression of the oxidative stress-responsive histone deacetylase SIRT1 was increased in the JSP
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BB rats; this finding also supports the decrease seen in NF-κB activity, since SIRT1 is known to
deacetylate p65 at lysine 310, thereby inhibiting its transactivation potential [272].
In a study by Nasrin and colleagues, JNK1 was recently shown to phosphorylate SIRT1
in kidney epithelial cells in response to hydrogen peroxide treatment, leading to an increase in
the enzymatic activity of SIRT1 [273]. In contrast to those results, we found that the increase in
JNK expression expected in JSP rats was associated with decreased SIRT1 nuclear expression in
the kidney. There is one explanation for the differences in these results. The cellular hydrogen
peroxide treatment in the study by Nasrin et al was of short duration (1 hour), with contrasting
results found with 6 hours of treatment. The authors proposed that prolonged exposure to
oxidative stress may lead to DNA damage and depletion of cellular NAD+ (a SIRT1 cosubstrate), thereby leading to decreased SIRT1 activity, while acute exposure to low levels of
oxidative stress may lead to increased SIRT1 activity in an initial attempt to promote cell
survival. In our study, severe oxidative stress was observed in kidney tissues of JSP rats, thus, it
is possible that this chronic oxidative stress did indeed deplete NAD+, causing a down-regulation
of SIRT1. Further confirmatory studies are needed to verify this course of events.
Interestingly, SIRT1 is well-known for its role in promoting longevity [274]. In a pilot
study we conducted with 8 JSP rats, only 3 rats survived the 10-week study period – a mortality
rate of 63%. In this study, JSP rats gained less weight and were often severely debilitated or
moribund at time of sacrifice. However, all JSP BB rats survived the study period, had more
regular weight gain, and did not demonstrate signs of illness at study end. It is possible that the
up regulation of SIRT1 seen in these animals is responsible for some of these benefits. Although
this study was not intended to examine the detailed signaling pathways involved in the
renoprotective effects of blueberries, but rather to examine the physiological effects of blueberry
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supplementation, our findings do present the possibility that one or more novel signaling
mechanism is at work. Additional studies are required to confirm these possibilities.
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CHAPTER 6
CONCLUDING REMARKS
Overall Summary of Findings
Hypertension-induced renal disease remains a leading cause of morbidity and mortality in
hypertensive patients [275-277]. The redox-responsive transcription factor NF-ĸB has been
shown to contribute to the deleterious effects of reactive species and inflammatory molecules on
kidney structure and function [278]. Although obvious putative roles for oxidative stress and
NF-ĸB exist in the development and progression of hypertension-induced renal disease [278281], the exact signaling mechanisms that perpetuate their effects on the hypertensive kidney
remain unclear. The overall hypothesis of this dissertation was that pharmacological or nonpharmacological approaches to reducing both inflammation and oxidative stress would prevent
or delay hypertension-induced renal injury in the spontaneously hypertensive rat (SHR), a model
for human essential hypertension.
In Chapter 2, we examined the effects of chronic pharmacological NF-κB blockade with
pyrrolidine dithiocarbamate (PDTC) on renal dysfunction and mitochondrial redox status in
spontaneously hypertensive rats (SHR). PDTC or vehicle was administered orally to 8-week-old
SHR and their respective controls for 15 weeks. We showed that PDTC treatment partially
attenuated the increase in SBP and normalized renal hemodynamic and excretory parameters and
ATP production rates in SHR. PDTC treatment also attenuated the higher levels of cytosolic and
mitochondrial ROS generation and tissue mRNA and protein expression levels of NF-κB and
oxidative stress genes in SHR without any comparable responses in control rats. These findings
suggest that NF-κB activation by ROS induces the cytosolic and mitochondrial oxidative stress

116

and tissue injury that contribute to renal dysfunction observed in SHR, and highlight a role for
NF-ĸB as a contributor to hypertensive renal disease in this rat model.
In Chapter 3, we focused on exercise as a non-pharmacological method to attenuate NFĸB and decrease oxidative stress in SHR.

Normotensive WKY rats and SHR underwent

moderate-intensity exercise training, beginning at age 7 weeks, for a total of 16 weeks. Exercise
training delayed hypertension, prevented oxidative stress and decreased NF-ĸB activation in the
kidney, while preserving renal hemodynamics and structure in SHR. These results again
highlight a role for NF-ĸB in the oxidative stress and renal dysfunction observed in SHR, and
suggest that exercise is a viable non-pharmacological option to decrease renal injury in the SHR
model of hypertension.
In Chapter 4, another non-pharmacological approach to preventing hypertension-induced
renal disease in the stroke-prone SHR model (SHRSP; a model of more severe renal disease than
is seen in SHR) was examined. In this model, we assessed the renoprotective effects of a
blueberry (BB)-enriched diet in the setting of hypertension. Blueberries have among the highest
antioxidant capacities of fruits and vegetables tested to date and are readily available to
consumers, and have been shown to decrease NF-ĸB activation and ROS production in vivo.
Male SHRSP were fed a BB-enriched diet (2% by weight) or an isocaloric control diet for 2
days, 6 weeks, or 12 weeks. In the 6- and 12-week studies, significant decreases in total ROS,
peroxynitrite, and superoxide production rates were observed in kidney tissues, which were
consistent with reduced pathology and improved function. Additionally, at both time-points,
measures of antioxidant status were enhanced. Similar measurements were made in rats fed the
same diet for only 2 days, which yielded evidence of increased oxidative stress.

This was

evidence of hormesis during this short-term exposure, which dissipated with time as indicated by
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the initiation of enhanced levels of catalase in the left ventricle and liver of BB-fed rats. Thus,
the addition of BB to the diet may be another viable non-pharmacological approach to prevent
hypertension-induced renal injury, and may operate via a hormetic effect.
As discussed in Chapter 4, BB-enriched diets are renoprotective and have antioxidant
properties in the SHRSP rat. In Chapter 5, we examined the effects of BB in this model in more
detail. When fed a ‘stroke-permissive’ diet (low in protein and altered sodium/potassium ratio)
and allowed to drink salt water, mortality will reach 100% in these animals by 15 weeks of age.
We examined the effects of BB supplementation of a stroke-permissive diet on mortality, renal
function and structure, NF-ĸB activation, and oxidative stress. SHRSP were fed a strokepermissive diet or a BB-supplemented stroke-permissive diet from 3 weeks of age to 15 weeks of
age.

Renal hemodynamic parameters were improved, blood pressure was decreased, ROS

production was decreased, and NF-ĸB activation was decreased in animals fed a BBsupplemented stroke-permissive diet. We also demonstrated that renal pathology was improved
in these animals. Further, we found an up regulation of the histone deacetylase, SIRT1, which
may be partly responsible for the decrease in NF-ĸB activation and improved survival seen with
BB diet. This study solidifies the possibility that addition of BB to the diet may represent a nonpharmacological option for preventing hypertension-induced renal injury.
Significance of Research
Despite advances in its treatment, hypertension remains the second leading cause of renal
failure in the United States [277]. Oxidative stress and inflammation are two major contributors
to the progression of hypertension and its associated renal effects [278-281]. Many current
antihypertensive therapies modulate both oxidative stress and inflammation in the kidney, but the
complexities of hypertension and its renal effects, along with the continued incidence of renal
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failure secondary to hypertension, continue to warrant the need for new strategies for and
approaches to its treatment.
An abundance of evidence exists that implicates the redox-sensitive transcription factor
NF-ĸB in the progression of oxidative stress and inflammation in the hypertensive kidney [278,
282-288]; however, several mechanisms are believed to contribute to NF-ĸB activation in
hypertension, and these mechanisms are far from completely understood.

Thus, a deeper

understanding of the interaction between oxidative stress and inflammation in the kidney, and a
better understanding of the contributory role of NF-ĸB to hypertension-induced renal disease is
critical to the development of new approaches to prevent or delay its progression.
We believe that our studies have helped identify new pharmacological and nonpharmacological approaches to prevent hypertension-induced renal injury.

It is clear that

attenuation of both oxidative stress and inflammation in the kidney are crucial to the prevention
of hypertension-induced renal damage, and we have shown that targeting NF-ĸB by drug
administration, aerobic exercise, or diet modification is an effective method of mitigating
hypertension and preserving renal structure and function. Overall, these proof-of-concept studies
have provided a basis for further studies that will advance the understanding of the relationship
among NF-ĸB, oxidative stress, and inflammation in the hypertensive kidney.
Future Directions
Although the aforementioned studies have made significant contributions to identifying a
molecular role for NF-ĸB in perpetuating oxidative stress and inflammation in the hypertensive
kidney, further studies are required to understand the underlying molecular mechanisms of NFĸB activation in the kidney.

Recent evidence suggests that several other transcription factors

can undergo ‘cross-talk’ with NF-ĸB, and therefore, the influence of oxidative stress and
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inflammation on these transcription factors in the setting of hypertension should be examined.
Also, there are several signaling pathways that activate NF-ĸB and promote oxidative stress;
however, it remains unclear which of these pathways is the major contributor to the hypertensive
changes in the kidney, and further studies are needed to determine this. NF-ĸB regulates the
transcription of many genes, and the effects of renal NF-ĸB activation on these genes should also
be examined in more detail.
Finally, an understanding of the temporal sequence of events leading to NF-ĸB
activation, oxidative stress, and inflammation in the hypertensive kidney will help us better
define appropriate interventions to prevent these deleterious renal effects in the setting of
hypertension. In summary, our studies have laid a foundation for a collection of future studies
aimed at better understanding the relationship between NF-ĸB, oxidative stress, and
inflammation, and their roles in the development and progression of hypertensive renal injury.
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